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Preamble 
It is becoming more apparent each day that despite a strong 
national commitment to excellence in health care, the re-
sources and personnel are finite. It is, therefore, appropriate 
that the medical profession examine the impact of develop-
ing technology on the practice and cost of medical care. 
Such analysis, carefully conducted, could potentially have 
an impact on the cost of medical care without diminishing 
the effectiveness of that care. 
To this end, the American College of Cardiology and the 
American Heart Association in 1980 established a Task 
Force on Assessment of Diagnostic and Therapeutic Cardio-
vascular Procedures with the following charge: 
The Task Force of the American College of Cardiology and 
the American Heart Association shall define the role of 
specific noninvasive and invasive procedures in the diag-
nosis and management of cardiovascular disease. 
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The Task Force shall address, when appropriate, the contri-
bution, uniqueness, sensitivity, specificity, indications, 
contraindications and cost-effectiveness of such specific 
procedures. 
The Task Force shall include a Chairman and six members, 
three representatives from the American Heart Associa-
tion and three representatives from the American College 
of Cardiology. The Task Force may select ad hoc mem-
bers as needed upon the approval of the Presidents of both 
organizations. Recommendations of the Task Force are 
forwarded to the President of each organization. 
The members of the Task Force are: George A. 
Beller, MD, Roman W. DeSanctis, MD, Harold T. Dodge, 
MD, J. Ward Kennedy, MD, T. Joseph Reeves, MD, Sylvan 
Lee Weinberg, MD and Charles Fisch, MD, Chairman. 
This document was reviewed by the officers and other 
responsible individuals of the two organizations and received 
final approval in October 1990. It is being published simulta-
neously in Circulation and the Journal of the American College 
of Cardiology. The potential impact of this document on the 
practice of cardiology and some of its unavoidable shortcom-
ings are clearly set out in the introduction. 
Charles Fisch, MD, F ACC 
0735-1097/911$3.50 
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I. Introduction 
Since its introduction by Garrett and colleagues (I) and 
Favaloro and colleagues (2) in 1969, the coronary artery 
bypass graft operation has become the most completely 
studied operation in the history of surgery. It has been 
shown to be highly effective in the relief of severe angina and 
under some circumstances has the capability for consider-
ably prolonging useful life. Nonetheless, outcome after the 
operation and its place in the overall management of patients 
with ischemic heart disease has not been easily defined 
because of I) the multifactorial nature and inherent complex-
ities of ischemic heart disease. 2) the multitude of treatment 
options that have become available, 3) the variability in the 
performance of the technical details of the operation and of 
the myocardial management. and 4) the variability in the 
methods of evaluating outcome after the operation and 
comparing it with that after other treatments. Even the 
minimal resources required to obtain good results have 
remained arguable, although this issue has been addressed 
on numerous occasions by governmental and nongovern-
mental groups since the report by the Inter-society Commis-
sion for Heart Disease Resources in 1972 (3). 
Because of the considerable personnel and facility re-
quirements of the coronary artery bypass graft operation. 
and the frequency with which it is indicated for a disease of 
high prevalence, the monetary costs of the procedure have 
become large and of individual, local and national concern. 
The reasons for these high costs have been addressed to 
some extent. but proposals for reducing them have dealt 
largely with costs. charges and reimbursement rather than 
substantive suggestions for making the procedure itself less 
expensive. 
The American College of Cardiology and the American 
Heart Association have designated a Task Force on Assess-
ment of Diagnostic and Therapeutic Cardiovascular Proce-
dures. That Task Force appointed a Subcommittee to de-
velop guidelines and indications for the coronary artery 
bypass operation. This is the report of the Subcommittee. It 
contains a distillation of current information. focused on 
present indications and practices. A new edition of this 
report will surely be indicated within 5 years, as new 
information becomes available. 
In this report. general information relating to the indica-
tions for the coronary artery bypass graft operation (Section 
VI) has been derived from comparison of the operation's 
benefits with those of initial medical treatment. Merely 
obtaining a consensus among experts. each of whom inevi-
tably has his or her bias. is no longer appropriate because of 
the large amount of reliable information that is available. The 
general indications are presented in the framework devel-
oped in other Task Force reports (Table I). However. this 
Subcommittee emphasizes that these general indications 
cannot take into account even the majority of the variables 
that are involved in most recommendations to patients. The 
treatment classes can better be defined for individual pa-
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Table L Classification of Indications for the Coronary Artery 
Bypass Graft Operation 
Treatment 
Class 
II 
III 
Description 
Conditions for which the operation is indicated 
on the basis of a demonstrated advantage 
over medical treatment in terms of longevity 
or relief of symptoms. or both. 
Conditions for which the operation is 
acceptable treatment but for which its 
advantages over medical treatment have not 
yet been fully defined. 
Conditions for which the operation is not 
generally considered to be indicated, because 
of lack of demonstrated advantage over 
medical treatment. 
tients from the patient-specific depictions of time-related 
comparative benefits of the coronary bypass operation rela-
tive to medical treatment (for details see Section X). 
The presence of percutaneous transluminal coronary an-
gioplasty as a commonly used alternative form of interven-
tional therapy is recognized. and the few comparisons that 
are possible have been made (Sections V and X). Recogniz-
ing the relative paucity of comparative information. the 
Subcommittee believed that this report needed to reflect 
some judgments as to the indications for the coronary bypass 
operation in an era when both medical treatment and coro-
nary angioplasty are available. This was done in Section VI. 
More secure recommendations can be made in the future. 
when more information is available. 
This entire report is intended to provide a framework that 
physicians can use in combination with other kinds of 
information and their best judgment as they offer recommen-
dations to the patient. who in the last analysis makes the 
decision. 
This Subcommittee expresses its appreciation for the 
constant support. advice and counsel of Charles Fisch. MD 
and Sylvan Lee Weinberg. MD from the parent Task Force. 
It is grateful for the support and considerable operational 
assistance of David Feild and Michael Forcinito of the 
American College of Cardiology. It also thanks Debbie 
Nuby, Brooks Counts and Nancy Ferguson for their enor-
mous contributions to the preparation of the material for this 
report and of the final document itself. 
II. The Coronary Artery Bypass 
Graft Operation 
A. The Operation 
The coronary artery bypass graft operation consists of the. 
construction of new pathways (conduits) between the aorta 
(or other major arteries) and segments of coronary arteriu> 
beyond stenosing or obstructing lesions for the purpose of 
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bringing blood to myocardium made ischemic by these 
lesions, 
Cardiopulmonary bypass with a pump oxygenator is used 
for nearly all coronary bypass graft operations. Thus, in 
addition to the surgeon, cardiac anesthesiologist and surgical 
nurse, a competent perfusionist is required (see Section 
VIII). 
Since the early years of the operation, reversed segments 
of autologous saphenous vein have been used as the conduit. 
Greater saphenous vein is expendable, generally available in 
sufficient length, appropriately sized to match the coronary 
arteries, capable of reaching beyond the stenoses of all 
diseased arteries, pliable enough to allow easy suturing and 
is autologous. When a greater saphenous vein is not avail-
able, the lesser saphenous vein may be used. Saphenous 
veins are used as free grafts, anastomosed proximally to the 
ascending aorta and distally to one or more coronary arter-
ies. Because increasing experience has documented the 
time-dependent diminution of patency in saphenous vein 
bypass grafts (see Section III), the left internal mammary 
artery (internal thoracic artery) is now widely used, partic-
ularly for revascularization of the left anterior descending 
coronary artery system. The internal mammary artery. left 
attached to its origin from the left subclavian artery, is 
mobilized from the chest wall and anastomosed to the left 
anterior descending artery. The right internal mammary 
artery can often be used in a similar fashion. About 95% of 
internal mammary arteries used in this way by experienced 
surgeons are patent 10 years after the coronary bypass 
operation (4) (see Appendix, Fig. AI), and failure to use the 
internal mammary artery in this manner has been demon-
strated to be a risk factor for premature late death after the 
operation (see Appendix, Fig. A2) (4-6). The use of the left 
or right internal mammary artery as a free graft from the 
ascending aorta to the left anterior descending artery pro-
vides almost comparable results (7). Currently available 
information indicates that the internal mammary artery 
should be used almost routinely for revascularizing the left 
anterior descending artery system in the coronary bypass 
operation. 
Use of bilateral internal mammary artery grafting has 
become popular, but as yet the available evidence does not 
support the hypothesis that long-term survival is increased 
by its use (5,6,8), and the risk of sternal wound complica-
tions is increased by the double internal mammary artery 
procedure in obese or diabetic patients (9). 
The patency advantage of the internal mammary artery 
when anastomosed to vessels other than the left anterior 
de~cending artery is uncertain (10). When neither internal 
mammary artery can be used, the right gastroepiploic artery, 
the inferior mesenteric artery or the inferior epigastric artery 
may. be used, although long-term advantages of these arter-
ie.s over saphenous vein grafts have not been demonstrated. 
Segments of radial artery, arm veins, allograft arteries and 
veioDs and synthetic tubes have been less satisfactory as 
conduits and should be used only as a last resort. 
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Current information (5,6) suggests that incomplete revas-
cularization is a risk factor for premature death and other 
unfavorable outcome events after coronary bypass surgery. 
As a result, anastomoses have been made to vessels with a 
diameter as small as I mm, with acceptable patency rates, 
and there has been more extensive use of sequential grafting, 
in which a conduit is anastomosed to two or three coronary 
arteries distally. It has been suggested (5,6) that the use of 
sequential grafting predisposes to graft failure and thus is a 
risk factor for unfavorable events late postoperatively, but 
this remains arguable. Endarterectomy of the diseased cor-
onary artery wall is occasionally utilized in combination with 
coronary artery bypass grafting and has yielded variable 
results. 
Intraoperative hemostasis should be obtained by meticu-
lous surgical technique, in preference to extensive use of 
blood products. The use of autologous preoperative or 
intraoperative blood donation, ultrafiltration devices in the 
pump oxygenator system, collection of intraoperatively shed 
blood by devices that wash and concentrate the erythro-
cytes, and the reinfusion of shed blood drained from the 
chest tubes during the early postoperative hours, minimize 
the amount of donor bank blood that must be used. In about 
50% of patients undergoing primary coronary artery bypass 
grafting and without preoperative anemia, no homologous 
blood should be required. However, important bleeding 
tendencies develop in some patients and require specific 
therapy. 
B. Myocardial Management 
Patients with coronary artery disease are more suscepti-
ble to major and minor myocardial injury immediately pre-
operatively, during induction of anesthesia, and befo:-e car-
diopulmonary bypass than are other patients, and precise 
management is necessary during these periods. Proper myo-
cardial management therefore begins preoperatively, with 
optimization of the patient's antianginal drug regimen. In 
general, beta-receptor and calcium channel blocking ther-
apy. and intravenous nitroglycerin if that is being adminis-
tered, should be continued until the patient comes to the 
operating room. Particular attention to avoidance of myo-
cardial ischemia is necessary during induction of anesthesia 
and in the period before cardiopulmonary bypass. 
Methods of myocardial management during cardiopulmo-
nary bypass are variable, probably because in uncompli-
cated cases good results are being obtained with all the 
methods that are commonly in use, and in complex and 
seriously ill patients few methods have been documented to 
result in less myocardial necrosis and better survival than 
any other. Most methods of myocardial management impose 
certain requirements on the sequencing and techniques of 
the coronary artery bypass operation, and changes from a 
successful method of myocardial management should not be 
made without the surgeon's consideration of the possible 
unfavorable effect of the combination of his or her particular 
546 KIRKLIN ET AL. 
ACC/AHA TASK FORCE REPORT 
technique of operation with a new method of myocardial 
management. The most important aspect of myocardial 
management is the continuous, thoughtful attention given to 
it by the surgeon and anesthesiologist throughout the oper-
ation. 
One successfully used technique includes no periods of 
global myocardial ischemia during moderately hypothermic 
cardiopulmonary bypass. When this method is used, the 
operation may be facilitated and outcomes improved by 
continuous ventricular fibrillation (11). A second success-
fully used method is that of intermittent occlusion of the 
ascending aorta, often preceded by the administration of 
nifedipine, lidoflazine or similar agents (12,13). A third 
technique that has given good results is the use of a single 
period of profoundly hypothermic global myocardial ische-
mia, achieved by profoundly cooling the heart before cross-
clamping and maintained by irrigating the pericardial space 
with cold saline solution (14). A fourth and commonly used 
technique is cold cardioplegia and a single period of global 
myocardial ischemia (15,16) with antegrade or retrograde 
infusion, or both, of a hyperkalemic solution. A fifth method 
that has given good results is cold sanguineous cardioplegia 
plus controlled initially hyperkalemic reperfusion and, under 
special circumstances, warm cardioplegic induction. This 
latter technique may have particular advantages when left 
ventricular function is chronically or acutely depressed 
preoperatively (17-20). 
After cardiopulmonary bypass, arterial hypotension or 
hypertension is avoided by appropriate management of 
blood volume and by drug therapy, and heart rate and 
rhythm are controlled, when necessary, by pacing with 
temporary epicardial atrial and ventricular pacing wires. 
Ventricular arrhythmias are minimized by appropriate myo-
cardial management during the coronary artery bypass op-
eration, but drug therapy may occasionally be necessary 
early postoperatively. 
Infrequently in uncomplicated cases with good myocar-
dial management, but more commonly in patients who come 
to the operating room with acute or chronic severe impair-
ment of left ventricular function, a temporary assist device is 
required after cardiopulmonary bypass. In this circum-
stance, the intraaortic balloon is used most commonly. Left 
ventricular and biventricular assist devices can be used 
when the balloon is ineffective, but the frequency of their 
need and their risk/benefit ratio when myocardial manage-
ment has been optimal remain to be determined. 
III. Status After the Coronary Bypass 
Operation (Outcome Events) 
The coronary artery bypass graft operation has a favor-
able effect on symptoms and useful life expectancy in many 
patients. However, it does not cure arteriosclerotic heart 
disease, and in most patients at some point, usually many 
years after operation, clinical evidence of myocardial ische-
JACC Vol. 17, No.3 
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mia returns and is followed by death, which in more than half 
the patients is related to recurrent myocardial ischemia. This 
section addresses the nature of the post coronary artery 
bypass state by categorizing and describing the results ofthe 
operation in terms of the probability of freedom from unfa-
vorable outcome events and the risk factors that work 
against optimal outcome. 
The interval between coronary artery bypass surgery and 
the time of occurrence of unfavorable outcome events is 
highly variable and of great importance to the patient and to 
society. Therefore the results (the probability of freedom 
from an outcome event) are depicted in a time-related 
manner. This is accomplished by use of 1) the life table 
method (most commonly and advantageously that of Kaplan 
and Meier [21]), reinforced by multivariable estimates of 
relative risks by the Cox-Breslow method (22,23), or 2) a 
parametric method in the multivariable hazard function 
domain (24). The multivariable analyses identify risk factors 
that independently affect outcomes and determine the 
strength of their effect. The analyses must be multivariable, 
parsimonious and conducted with medical knowledge, be-
cause 1) the effects of risk factors are incremental, 2) some 
risk factors interact with others in specific ways, and 3) some 
characteristics that seem to be risk factors are surrogates for 
more fundamental risk factors. 
This is all necessary because patients with coronary 
artery disease requiring treatment have characteristics that 
may vary enormously from one patient to another. Many of 
these characteristics are prognostically important, whatever 
the form of treatment of the patient. Some patients have 
other important diseases that have an impact on outcome 
after coronary artery bypass surgery and other kinds of 
treatment, and thus on the indications for the various forms 
of therapy. The operation is complex (Section II), and can 
vary considerably among patients, surgeons and institutions. 
It follows that the simple depiction of the time-related 
freedom from an untoward event in a heterogeneous group 
of patients is of limited value in understanding the nature of 
the post coronary bypass state, the appropriateness and 
effectiveness of the bypass operation in comparison with 
alternative methods, and the probable outcome in a specific 
patient coming for treatment of ischemic heart disease. 
A. Survival (Freedom From Death) 
Death from any cause is a secure end point with which to 
judge the efficacy of coronary artery bypass surgery, and to 
compare it with alternative forms of therapy. In general, 
about 96.5% of heterogeneous groups of patients survive at 
least 1 month after the operation, and 95%, 88%, 75% and 
60%, respectively, survive 1, 5, 10 or ~15 years after the 
operation (Table 2). The time-related survival, and the 
hazard function are shown in Figure 1. (The hazard function 
depicts the instantaneous risk of an event, such as death, at 
each moment in time after the starting point in time [time 
zero], which here is the time ofthe bypass operation. It may 
lACC Vol. 17, No.3 
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Table 2. Survival After the Coronary Artery Bypass Graft Operation* 
Report Month 
European Randomized Trial (25) 96.8 
CASS Randomized Trial (26,27) 98.5 
V A Randomized Trial (28) 95 
V A Randomized Trial, left main 94 
disease (29) 
V A Randomized Trial, unstable 97 
angina (30,31) 
CASS Registry (3 vessel disease, 96.8 
mild angina) (32) 
CASS Registry (3 vessel disease, 95.1 
severe angina) (33) 
Bishop lecture (UAB) (34) 99 
Katholieke Universiteit, 98 
Leuven, Belgium (Sergeant 
and colleagues) (5,6) 
Percent Freedom From Death 
5 
Year Years 
95.5 91.3 
98.1 94.7 
93 83 
93 80 
95 86 
95.9 90 
93.9 87 
98 86.5 
97 92 
10 
Years 
77 
82 
64 
81 
15 
Years 
57 
*The differing prevalence of risk factors in the different groups is the most likely explanation for the differing percent survival data. CASS = Coronary Artery 
Surgery Study; UAB = University of Alabama at Birmingham: VA = Veterans Affairs. 
be thought of as the rate at which that event is occurring at 
each point in time after time zero. The percent of patients 
free from the event [here the percent survival] at any point in 
time after time zero represents the accumulation of all the 
hazard functions, or rates, up to that point.) 
The prevalence of risk factors in a group of patients, and 
the degree to which they are present in individual patients, 
decreases or increases the probability of death after coro-
nary artery bypass surgery. The risk factors for death after 
the coronary bypass operation are shown in Table 3, and 
most of the preoperative risk factors are also risk factors for 
death in patients with arteriosclerotic coronary artery dis-
ease managed by any method. The risk factors for other 
unfavorable outcomes after the bypass operation are similar 
to these, although not identical. Many risk factors are 
specific to the early period after operation; others have their 
effect late postoperatively. 
Patients may live comfortably and productively after 
coronary artery bypass surgery, or they may have other 
interval events and may undergo repeat bypass surgery, 
coronary angioplasty or even cardiac transplantation. 
B. Modes of Death 
The precise cause of death can uncommonly be assigned, 
and this is particularly true in the complex situation of 
ischemic heart disease. Modes of death can be assigned with 
reasonable reproducibility. Cardiac death is the most prev-
alent mode (Table 4). 
Studies using cardiac death (rather than all deaths) as an 
end point after the coronary artery bypass operation have 
demonstrated that 1) the probability of cardiac death early 
postoperatively is less after operations performed in the 
recent era than in earlier years, 2) the more severe and 
extensive the coronary artery disease, the greater is the 
comparative benefit of the operation over medical treatment, 
and the less severe and extensive the disease the less the 
comparative benefit, and 3) the more severe the left ventric-
ular dysfunction, the greater the comparative benefit of the 
operation (35) (see Appendix, Fig. Bl and B2). The risk 
factors and inferences when using cardiac death as the end 
point are similar to those derived when all deaths are used as 
the end point, and the two kinds of analyses reinforce each 
other. 
C. Return of Angina 
The evidence, both symptomatic and from graded exer-
cise testing, is complete that the coronary artery bypass 
operation relieves angina in most patients. However, the 
return of angina is the most prevalent of the postoperative 
ischemic events (Fig. 2). The hazard function for return of 
angina begins to rise after about 5 years (Appendix, Fig. B3). 
The return of angina very early after coronary bypass 
surgery, typically recognized with resumption of activity, 
usually is due to incomplete revascularization or early 
closure of grafts. Angina occurring later usually is a reflec-
tion of narrowing or closure of one or more grafts or 
progression of native vessel disease, or both. 
The risk factors for the return of angina are similar but not 
identical to those for death (see Appendix B). Nonuse of the 
internal mammary artery is not a risk factor (Appendix, Fig. 
B4), and this observation suggests that survival depends in a 
major way on a continuing blood supply to the left anterior 
descending artery with its septal branches, while angina may 
return as a result of recurrent or new ischemia in the 
distribution of the right or circumflex coronary systems 
without necessarily predicting death. 
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D. Perioperative and Postoperative 
Myocardial Infarction 
Perioperative myocardial infarction is usually defined by 
the appearance of new Q waves on the ECG, but non Q wave 
perioperative myocardial infarction may occur (usually iden-
tified by changes in serum levels of myocardial enzymes) and 
may be significant clinically. Peri operative myocardial in· 
farction is an important risk factor for later death (36) but its 
incidence has been reduced from about 5% to 8% in the 
Coronary Artery Surgery Study (CASS) era to about 2.5% 
currently (37,38) as methods of myocardial management 
before, during and early after operation have improved. 
Although documentation is difficult, the evidence sug-
gests that postoperative myocardial infarction after the pe· 
rioperative period is uncommon in the first few years after 
bypass surgery, and by 5 years postoperatively about 95% of 
patients are still free of nonfatal and fatal postoperative 
myocardial infarction (Sergeant PT, Blackstone EH, 
Lesaffre E, Flameng W, Kirklin JW. Unpublished study, 
1990). However, only about 85% and 65% are free of 
I" 16 
I" 16 
Figure 1. A, Survival probability at each moment in time 
after the coronary bypass operation in a heterogeneous 
group of patients (5,6). The circles represent individual 
deaths, positioned along the horizontal axis at the time of 
death and actuarially along the vertical axis. The vertical 
bars represent the 70% confidence intervals of the actu-
arial estimate. The numbers in parentheses indicate the 
number of patients still being traced at the time of the 
actuarial estimate. The solid line is a nomogram (plot) of 
the parametric survivorship, and the dashed lines enclose 
the 70% confidence intervals. The dash·dot·dash line is the 
survivorship of an age-gender-race-matched general pop-
ulation. (All figures in this report are presented in this 
general format.) B, Hazard function for death in the same 
group of patients. Note 1) the early, rapidly declining 
phase, merging with the constant phase about 3 months 
after the coronary bypass operation, 2) the constant 
phase, and 3) the slowly rising third phase of hazard, 
beginning about 5 years after the operation. 
myocardial infarction 10 and 15 years, respectively, after 
operation. As in the case of angina, the hazard function for 
postoperative myocardial infarction begins to increase about 
5 years after the coronary bypass operation. 
The risk factors for myocardial infarction after the oper-
ation are similar to those for death and other unfavorable 
events after the operation. 
E. Sudden Cardiac Death After the Coronary 
Bypass Operation 
Sudden cardiac death is uncommon in general after the 
bypass operation (see Table 4). By 10 years after undergoing 
the operation, 95% of patients are free of sudden death, as 
are about 90% by 15 years (39). 
F. Heart Failure 
Only 5% to 10% of deaths after the coronary bypass 
operation occur in patients with the syndrome of chronic 
heart failure (see Table 4). In part, this is because patients 
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Table 3. Preoperative and Operative Risk Factors for Increasing 
the Probability of Death Early or Late After a Primary Coronary 
Artery Bypass Operation* 
Risk Factors 
Demographic 
Age at coronary bypass operation (older) 
Body size (smaller) 
Gender (female) 
Clinical status 
Angina (Canadian class 0 to IV) (more severe) 
Unstable angina 
Response to stress testing (more severe) 
Acute myocardial infarction 
Hemodynamic instability (grade 0 to 4) (more severe) 
NYHA functional class (I to IV) (higher) 
Distribution and severity of coronary artery disease (greater) 
Left ventricular dysfunction (grade 0 to 4) (more severe) 
Aggressiveness of arteriosclerotic process 
Diffusely diseased coronary arteries 
Peripheral vascular disease 
Cerebrovascular disease 
Hyperlipidemia (more severe) 
Age at coronary bypass operation (younger) 
Coexisting disease 
Diabetes 
Hypertension 
Pulmonary disease (more severe) 
Stroke 
Smoking 
Surgical factors 
Date of operation (earlier) 
Nonuse of IMA to LAD 
Incomplete revascularization 
Perioperative myocardial infarction 
(inadequate myocardial management) 
Surgeon 
Institutional factors 
'This table is not the result of a specific multi variable analysis, but is a 
composite depiction of data from many studies. IMA = internal mammary 
artery; LAD = left anterior descending coronary artery; NYHA = New York 
Heart Association. 
with ischemic heart disease and important chronic heart 
failure usually have severe left ventricular dysfunction as a 
result of extensive myocardial scarring, and are not advised 
to undergo bypass surgery (see Section VI). 
G. Unsatisfactory Quality of Life 
It is nearly impossible to quantify an unsatisfactory 
quality of life after the coronary bypass operation, even 
though it is one of the most important unfavorable outcome 
events. This relates in part to the fact that an unsatisfactory 
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Table 4. Modes of Death After the Coronary Artery 
Bypass Operation* 
549 
All Deaths After CABG 
Mode of Death No. % of 545 
Cardiac 298 54.7 
Cardiac failure t 216 40 
Acute 145 26 
Subacute 35 7 
Chronic 36 7 
Sudden 78 14 
Arrhythmic 4 0.7 
Cancer 90 17 
Neurologic 53 10 
Trauma 27 
Pulmonary failure 19 
Pulmonary thromboembolism 10 2 
Hemorrhage 10 2 
Acute intraabdominal catastrophe 6 
Hepatic failure 6 1 
Infection 5 0.9 
Renal failure 0.6 
Miscellaneous 8 1 
Uncertain 10 2 
Total 545 100 
'Data from Sergeant PT, Blackstone EH, Lesaffre E, Flameng W, Kirklin 
JW. Unpublished study, 1990. tCardiac failure (which could be termed 
cardiac death) is considered acute when it occurs within 3 days of an operation 
or a new myocardial infarction, subacute when it occurs between 3 days and 
6 weeks of such events and chronic when it is not preceded by an identified 
proximal previous event. 
quality of life is a composite of at least freedom from limiting 
angina or heart failure, the preservation of a reasonable 
exercise capacity and reasonable freedom from the need for 
medication, rehospitalization and reintervention. Most sur-
viving patients have a satisfactory quality of life early after 
the bypass operation, but the probability of retaining this 
quality begins gradually to decline after about 5 years (40). 
The rate of decline in the quality of life is probablY similar to 
that of the freedom from angina (see Fig. 2). 
As in all other outcome events, the probability of freedom 
from an unsatisfactory quality of life in an overall heteroge-
neous group is of limited value when considering individual 
patients. The risk factors for an unsatisfactory quality of life 
after the coronary bypass operation have not been rigorously 
defined but are probably a combination of those for the 
return of angina and those for failure to return to work. 
H. Failure to Work 
Failure to work is, like other unfavorable outcome 
events, a time-related phenomenon. However, the relation 
to time has been less thoroughly studied for this outcome 
event than for many other outcome events, but it is probably 
similar to that of angina. Thus freedom from failure to work 
probably begins to diminish about 5 years after the coronary 
bypass operation (40). 
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A common belief is that the coronary artery bypass 
operation does not improve the prevalence of gainful em-
ployment among patients with ischemic heart disease 
(41,42), but this has not been a universal finding (43,44). The 
failure to take into account the differing prevalences of risk 
factors for failure to work after the coronary bypass opera-
tion explains many of the discrepancies in results (44). 
Patients who were working before the operation have the 
highest prevalence of being employed after the operation 
(42,45). However, under favorable circumstances, as defined 
by the risk factors (Table 5), >80% of patients not working 
at the time of bypass surgery are working 1 year later; only 
$20% are working postoperatively when the risk factors are 
unfavorable (47,48). Likewise, patients who are free of 
angina after the bypass operation are considerably more 
likely to be working than are those with angina (45). 
Further confusing this issue are the vagaries of disability 
programs and the reluctance of employers to rehire patients 
who have had bypass surgery even if they are asymptomatic. 
I. Neurobehavioral and Neurologic Outcomes 
After Coronary Bypass Surgery 
Unrelated to the cardiac aspects of the coronary bypass 
operation, the damaging effects of the cardiopulmonary 
bypass usually required for the operation result in neurobe-
havioral disturbances in some patients. These are sufficiently 
mild that they may not be apparent unless patients are tested 
specifically for them, and, their prevalence has been some-
what reduced recently by the incorporation of appropriate 
filters in the arterial line from the pump oxygenator to the 
patient. As many as 75% of patients exhibit these subtle 
defects when tested 8 days after operation, but by 3 months 
postoperatively only about 10% to 30% exhibit them (49,50). 
The prevalence is unfavorably affected by postoperative 
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Figure 2. Time-related probability of freedom from 
the first return of angina after the coronary artery 
bypass operation in the same heterogeneous group 
of patients referred to in Figure 1. (Sergeant PT, 
Blackstone EH, Lesaffre E, Flameng W, Kirklin 
JW. Unpublished study, 1990) (see Appendix B for 
details). 
14 16 
anxiety and depression, and by older age (51). Only rarely 
are patients aware of or handicapped by these defects (52). 
Gross neurologic defects, usually in the form of transient 
or permanent sequelae of strokes, are more serious but 
fortunately are considerably less common. They are more 
likely to result from embolization of atherosclerotic debris 
Table 5. Risk Factors for Time-Related Failure to Work After the 
Coronary Artery Bypass Operation* 
Demographic 
Age at operation (older) 
Educational time (shorter) 
Preoperative work conditions 
Risk Factors 
Physical effort on the job (grade) (greater) 
Duration of absence from work (longer) 
Income from work (lower) 
Clinical status 
Duration of preoperative angina (years) (longer) 
Severity of preoperative angina (greater) 
Aggressiveness of arteriosclerotic process 
Peripheral vascular disease (more) 
Coexisting disease 
Alcohol intake (more) 
Surgical factors 
Date of operation (earlier) 
Postoperative factors 
Duration of absence of angina after coronary bypass surgery (shorter) 
Cardiac rehabilitation program (nonparticipation) 
'Inferences based on the work of Boulay et al. (44) and Vamauskas et 
al. (46). 
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from the ascending aorta or from air embolization than from 
the damaging effects of cardiopulmonary bypass. The prev-
alence is about 0.5% in relatively young patients, but rises to 
about 5% in patients >70 years of age and to about 8% in 
those >75 years (53,54). 
J. Graft Disease and Patency 
The highest patency rates for coronary bypass grafts are 
associated with use of the left internal mammary (thoracic) 
artery to bypass important proximal stenoses of the left 
anterior descending coronary artery. These patency rates 
are approximately 95% at 10 years after operation (4). and 
closure of the mammary artery after that time is uncommon. 
Few factors appear to affect the patency rate of the internal 
mammary artery when anastomosed to the anterior descend-
ing artery. This favorable performance of the internal mam-
mary artery when anastomosed to the left anterior descend-
ing coronary artery is probably due to its particular wall 
structure and function. and the potentially large runoff 
through the left anterior descending artery system. Internal 
mammary artery grafts to other vessels appear to have lower 
patency rates late postoperatively than do those to the left 
anterior descending artery. and these may be no greater than 
those of vein grafts (l0). 
The patency rates of the other arterial conduits currently 
in use (see Section II) have not as yet been reliably deter-
mined. 
Saphenous vein grafts used as conduits in the coronary 
artery bypass operation develop diseases of their own. 
which contribute importantly to ultimate stenoses and oc-
clusions. Diffuse intimal hyperplasia is a universal finding in 
vein grafts that have been in place for > I year. Perhaps 
unrelated to this finding. about 10% of vein grafts close 
within the first few postoperative weeks. at least when 
anti platelet therapy is not used. By 3 to 5 years after vein 
graft placement. frank atherosclerotic lesions are identifiable 
in many of these grafts (55). By 10 years after insertion. half 
of vein grafts still patent have undergone at least some 
arteriosclerotic changes (56). These changes result in local-
ized or diffuse narrowings which progress at a highly vari-
able rate. 
The 10 year patency rate of vein grafts appears to be 
highly variable. and in some reports (57,58) only 50% to 
60% overall are still patent. Other reports (4) indicate that 
the patency rate of vein grafts depends in part on the 
coronary artery to which they are anastomosed. with 
about 80% of those to the left anterior descending artery 
being patent at 10 years. and only 70% to 75% of those to 
other vessels. The mean yearly attrition rate of vein grafts 
after 10 years is about 5%'year- 1 (57.59). Arm veins have a 
still lower prevalence of patency (60)' as do synthetic 
conduits. 
Lesser distal runoff. determining as it does the flow 
through the graft, reduces saphenous vein graft patency 
rates. Therefore, patency rates are lower when the anasto-
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mosis is to small coronary arteries and to arteries supplying 
areas with considerable scar. Whether the placement of two 
or more distal anastomoses on a vein graft (sequential 
grafting) increases or decreases patency rates is arguable. 
Patency rates of saphenous vein grafts can be improved 
by the administration of antiplatelet drugs (see Section VII). 
K. Reintervention after Coronary Bypass Surgery 
Reintervention, either a second bypass operation or cor-
onary angioplasty, is sometimes indicated in the years after 
the first bypass operation, because of evidence of important 
recurrent myocardial ischemia. As would be expected, rein-
tervention is uncommon within 5 years of the bypass oper-
ation but more frequent thereafter (Sergeant PT, Blackstone 
EH, Lesaffre E. Flameng W, Kirklin JW. Unpublished 
study, 1990). A few patients require a third bypass opera-
tion. and a very few a fourth. 
The early risks of a second bypass operation are about 
twice those of a first bypass operation. Most of the increased 
risks are related to an increased prevalence of unfavorable 
risk factors in patients undergoing a second bypass operation 
(60a). 
IV. Comparisons of Coronary Artery Bypass 
Surgery With Medical Therapy 
Comparisons of outcome after the coronary bypass oper-
ation with that after alternative forms of treatment are best 
done in terms of the time-related comparative benefit (ap-
propriateness) of the bypass operation (35). End points in 
such comparisons may be freedom from death (survival), 
from angina. from fatal or nonfatal myocardial infarction, 
from sudden death or from the coronary bypass operation 
itself (a repeat bypass operation if the initial therapy was the 
bypass operation. otherwise the first bypass operation after 
some other form of initial therapy). Death is the most 
unequivocal of these. and the available information suggests 
that the time-related comparative benefit of the coronary 
bypass operation is at least as great when any of the other 
end points are used. Therefore. and because of limitations of 
space. survival is the end point used for the comparisons in 
this section. 
The methodology for making the comparisons used by the 
Subcommittee are presented in Appendix C. 
The comparisons in this report refer to the initial coro-
nary bypass operation in comparison with some other form 
of initial therapy. The "initial" refers to therapy at the time 
of decision-making. whether it is the first or a subsequent 
episode of decision-making. All analyses of outcome de-
scribed in the report are by the so-called intention-to-treat 
principle. and patients are not deleted (censored) from the 
analyses if at some subsequent time a different treatment is 
used (61). Unfortunately. there is no valid way to compute 
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Figure 3. Comparisons of survival after nonrandomly assigned 
initial coronary artery bypass surgery, compared with that after 
initial medical treatment, according to the severity of pretreatment 
angina. in an otherwise heterogeneous group of patients with three 
vessel disease (32,33). (See prevalences of risk in the patients 
depicted in the accompanying table). A and B, Patients with class I 
or II angina. A, Survival data for these patients. B, Comparative 
benefit, in terms of survival, in these patients. There is a small 
benefit of initial medical treatment for the first several months after 
the start of therapy, but after 9 months there is an increasing surgical 
advantage for at least 6 years; this advantage is unlikely to be due to 
chance alone. (See Appendix C for methodology.) C and D, Respec· 
tive findings in class III or IV angina. C, The 5 year survival after 
coronary bypass surgery is little different from that of patients with 
angina class I or II, but survival after initiation of medical treatment 
is considerably less than that of patients with less severe angina. D, 
The comparative surgical benefit at all time periods is considerably 
greater than in patients with class I or II angina. E, Table indicating 
prevalence rate of risk factors. 
outcome after isolated medical treatment, coronary bypass 
surgery or coronary angioplasty in an era in which later 
crossover after any form of initial therapy is not only allowed 
but is often good management (61). 
The comparisons in this section are based on the known 
risk factors but of necessity address only a single risk factor 
at a time. As such, they are useful in providing background 
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Prevalences of Risk Factors in Patients With Three 
Vessel Disease and Class I or II Angina From the Coronary 
E 
Artery Surgery Study Registry (1987) (32); and From Similar 
Patients With Angina Class III-IV (33). 
Angina I-II Angina III-IV 
Characteristic * Surgical Medical Surgical Medical 
Patients (n) 443 413 1921 679 
Age (yr) 54 ± 9 54 ± 9 56 58 
LV score > lOt 33% 49% 40% 58% 
Ejection fraction 0.56 0.51 
Prior myocardial infarction 58% 70% 62% 67% 
Hypertension 36% 44% 
Diabetes 16% 21% 
'Mean value, or % of n; tequivalent to an ejection fraction <0.40. LV = 
left ventricular. 
information, but comparisons in this format are of limited 
value in decision-making for individual patients, because all 
of the patient-specific risk factors together, not just one 
alone, determine outcome in individual patients. Thus the 
patient-specific comparisons for individual patients, dis-
cussed in Section X, should be more useful as an aid to 
decision making. 
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A. Comparison According to Severity of Angina 
In general, the more severe the angina, the less favorable 
the outcome after initial medical therapy. while outcome 
after the coronary artery bypass operation as initial therapy 
is relatively unaffected by the preoperative severity of an-
gina (32,33) (Fig. 3). This relates to the fact that the severity 
of the angina is a surrogate (substitute) for the magnitude of 
the decrement in myocardial blood flow reserve. and this 
risk factor is neutralized by the coronary bypass operation 
when essentially complete revascularization is achieved. 
Thus the benefit of initial surgical treatment. compared with 
that of initial medical treatment, is in general greater. the 
more severe is the angina. 
B. Comparison According to Objective 
Evidence of Ischemia 
The inferences concerning angina. a symptom of revers-
ible myocardial ischemia. are reinforced by similar compar-
ative benefits when the amount of reversible myocardial 
ischemia is examined by electrocardiographic (ECG). func-
tional or perfusion evidence of ischemia during graded 
exercise testing. The more severe the exercise-induced 
ischemia, the greater the comparative benefit of initial cor-
onary bypass operation (see Appendix Fig. C I) (25). 
C. Comparison According to Instahility 
of Angina 
Overall. patients with unstable angina and with continu-
ing medical surveillance have a 5 year survival rate that is 
similar whether the initial treatment after the instability has 
subsided is surgical (the coronary bypass operation) or 
medical (see Appendix Fig. C2) (31). However. about 20% of 
patients initially given medical treatment are advised to have 
and actually undergo the coronary bypass operation within 6 
months of the initial treatment and nearly 50% undergo the 
operation within 5 years (31). This observation emphasizes 
the importance of continuing surveillance of patients with 
unstable angina receiving initial medical therapy. 
The importance of the interrelation of apparently inde-
pendent risk factors is emphasized by the fact that. when 
unstable angina is combined with three vessel coronary 
artery disease, there is a considerable comparative benefit 
from initial surgical rather than initial medical treatment with 
a low early risk and for at least 5 years (31) (see Appendix 
Fig. C2). in contrast to the findings in a heterogeneous group 
of patients with unstable angina. 
D. Comparison According to Location and 
Severity of the Stenoses 
The early and late risks of the coronary bypass operation 
are not increased by the presence of left main coronarv 
artery disease unless the stenosis is extremely severe 
(>90%) (6,34), but the risks of initial medical treatment are 
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considerably increased. As a result, in general there is 
comparative benefit in favor of initial coronary bypass 
surgery rather than initial medical treatment, which becomes 
greater as the severity of the left main stenosis increases (29) 
(see Appendix Fig. C3). 
In general. the greater the number of major coronary 
arteries with important stenoses, the less the time-related 
survival with initial medical treatment. Since the time-related 
survival after coronary bypass surgery is only weakly affected 
by the number of diseased vessels (33,35), the surgical benefit 
is greater. the greater the number of diseased vessels. The 
greater is the number of vessels with important proximal 
stenoses. the greater the comparative benefit of surgery, be-
cause survival after initial medical treatment declines as the 
number of proximal stenoses increases whereas that after 
coronary bypass surgery does not (see Appendix Fig. C4) (33). 
A proximal stenosis in the left anterior descending coro-
nary artery appears particularly to increase the comparative 
surgical benefit (25) (see Appendix Fig. C5). 
E. Comparison According to Left 
Ventricillar Function 
In general. the more severe is the left ventricular dysfunc-
tion. the greater is the comparative benefit from surgery (see 
Appendix Fig. C6). even though the early and late results of the 
coronary bypass operation are somewhat less good in patients 
with important left ventricular dysfunction than in those with 
essentially normal left ventricular function (33,35). The com-
parative benefits of the coronary bypass operation are partic-
ularly great when associated risk factors such as extensive 
coronary artery disease and severe ischemia are also present 
(36). 
Extreme left ventricular dysfunction is usually an indication 
of extensive left ventricular scarring, with little or no "revers-
ible ischemia." Under these circumstances, the prognosis with 
both initial medical and initial surgical treatment is limited. 
However, the precise level of ejection fraction (or CASS score) 
that is indicative oflack of any substantial surgical benefit is not 
yet established but is probably less than 0.2 or even 0,15 (see 
more detailed discussion in Section VI). 
Patients with important left ventricular dysfunction but 
truly without reversible ischemia do not benefit from the 
operation, 
F. Comparison According to Age 
Currently available information indicates that the com-
parative advantages of coronary artery bypass surgery in 
patients >65 years of age are similar to those in younger 
patients. There must be an age level above which the 
comparative benefits of surgical treatment lessen, other 
factors being equal. but currently this level has not been 
identified, Surgical experiences suggest that it may be at > 70 
years of age. although hospital stay is longer and early 
complications more frequent in the very elderly (62-68), 
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G. Comparison According to Length of 
Follow-Up 
90 
The probability of survival after the coronary artery bypass 
operation and that after initial medical therapy have tended to 
approach each other by the time the follow-up periods have 
become 10 to 15 years in length (see Section XI and Fig. 6 and 
7). The explanations for this are complex and include the 
probability that progression of atherosclerotic disease in vein 
grafts is more rapid than that in native coronary arteries. It 
remains to be determined whether aggressive risk factor mod-
ification after revascularization and widespread use of the 
internal mammary artery for grafting the left anterior descend-
ing artery will change this situation. 
H. Summary 
The foregoing has described briefly the available informa-
tion concerning the advantages, when they exist, of the coro-
nary artery bypass operation over medical treatment. A 
broader, conceptually useful view of the role of interventional 
therapy in patients with ischemic heart disease can be obtained 
from Figure 4, adapted from the study by Califf et al. (35). 
Survival with medical treatment is dependent on the individu-
al's patient-specific risk factors. (Survival, or more specifically, 
the freedom from cardiovascular death, is depicted along the 
horizontal axis of Fig. 4). The comparative benefit of coronary 
artery bypass surgery, depicted along the vertical axis. is 
100 
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Figure 4. Nomogram of an equation, describing the 
comparative benefit (difference in percent freedom from 
cardiovascular death after two treatments) at some time 
(t) of the coronary artery bypass operation (or angio-
plasty) over medical treatment. This comparative ben-
efit, along the vertical axis, is determined by the interre-
lation between 1) the percent (probability of) freedom 
from cardiovascular death at time (t) after the initiation 
of medical treatment, and 2) the number of coronary 
arteries whose stenoses have been completely neutral-
ized by interventional therapy (indicated by the isobars). 
The values of the isobars are, in fact, the hazard ratios, 
and the hazard ratios represent the effect of comparative 
benefit of the number of arteries with important stenosis 
in patients undergoing a coronary bypass operation. The 
nomogram pertains when time (t) is between 2 and 7 
years (time of approximately proportional hazards) after 
the coronary bypass operation (or angioplasty) or the 
initiation of medical treatment. and when the early risks 
of intervention (coronary bypass operation or angio-
plasty) are negligible. 
The abstract equation is 
y (the comparative benefit) = SCABG(t) - SM(t) 
SM(t)h = SCABG(t). 
CABG = coronary artery bypass grafting; h = hazard 
ratio; LM = left main coronary artery; SCABG = survival 
after CABG; SM = survival with medical treatment; VD 
= vessels diseased (stenosis ~50%). Data supplied by 
CaliffRM, Harrell FE Jr. Personal communication, 1990 
as supplement to Ref. 35. 
dependent on 1) the number (and type) of coronary arteries 
whose stenoses have been completely "neutralized" by the 
bypass operation (represented by the isobars), and 2) the 
survival with medical treatment. It follows that the potential 
comparative benefit from the bypass operation is limited by the 
number of vessels with important stenoses to be neutralized. A 
more subtle implication is that survival after the operation is 
the least good in patients anticipated to have poor survival with 
medical treatment, even though the comparative benefit is the 
greatest; conversely. the survival rate is highest in patients 
anticipated to have good survival with medical treatment, even 
though the comparative benefit is the least in such patients. 
Study of Figure 4 indicates that, conceptually, even patients 
with single vessel disease, neutralized by the coronary bypass 
operation, achieve some comparative benefit with respect to 
survival (assuming that the risk of the interventional procedure 
itself is negligible). However, when left ventricular function is 
good and all other risk factors indicate a high probability of 
survival with medical treatment (95% freedom, along the 
horizontal axis), the comparative benefit is small, probably not 
identifiable, and of insufficient magnitude to indicate an advan-
tage for the bypass procedure. The benefit is greater in patients 
with two and three vessel disease. When left ventricular 
dysfunction is present, and this and other risk factors move the 
patient to the left on the horizontal axis, the comparative 
benefits of one, two and three vessel disease become still larger 
and more easily identified. 
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Although these concepts were derived from an analysis in 
which the coronary bypass operation was the interventional 
therapy, they apply to coronary angioplasty as well. How-
ever, it must be remembered that the isobars in Figure 4 
represent vessels whose stenoses have been completely 
neutralized by the intervention. When they are not, the 
figure does not apply. 
V. Comparisons of the Coronary Bypass 
Graft Operation With Coronary Angioplasty 
The paucity of proper risk-adjusted comparisons, and the 
absence of comparisons from randomized trials. among I) 
coronary artery bypass grafting, 2) percutaneous transluminal 
coronary angioplasty, and 3) medical treatment, is severely 
limiting to this report and to clinical practice. The results of the 
ongoing trials designed to compare these treatments will not be 
known for a considerable period of time. Yet, ignoring the 
effect of the existence of coronary angioplasty on the indica-
tions for the coronary bypass operation is unrealistic (see 
Section VI for further details). Therefore. the comparative 
information that exists is presented. 
Coronary angioplasty offers. in general, a major compar-
ative advantage over the coronary bypass operation in that 
no surgical procedure and usually no cardiopulmonary by-
pass are required, the hospital stay is shorter. and proce-
dure-related disability is generally less. This could make 
coronary angioplasty the advisable therapy in patients in 
whom the freedom from unfavorable outcome events after 
that procedure can reliably be shown to be similar to the 
freedom after the bypass operation. 
A. Survival 
Nonrisk-adjusted comparisons of survival out to 5 years 
in heterogeneous groups of patients have shown no or small 
differences in this regard between initial coronary bypass 
surgery and initial coronary angioplasty (69-73) (See Appen-
dix Figure Dl, which shows a small advantage of coronary 
angioplasty, not confirmed when risk-factor adjustment was 
made). Risk-adjusted comparisons are few, but they suggest 
that most elderly patients with three vessel coronary artery 
disease have a considerable comparative survival benefit 
from an initial coronary bypass operation over that obtained 
by initial coronary angioplasty (see Appendix Fig. D2); that 
some patients with two vessel disease receive a considerable 
comparative benefit from the bypass operation relative to 
angioplasty; and that few patients with one vessel disease 
have a comparative benefit from the bypass operation over 
angioplasty with respect to survival (73). 
B. Freedom From Recurrence of Angina 
Most comparative studies indicate that the duration of 
freedom from angina is less after initial coronary angioplasty 
than after initial coronary bypass surgery (69,71-75) (see 
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Appendix Fig. D3), although in one of the studies with a 
follow-up of about 2 years the difference was small (74). 
C. Freedom From Myocardial Infarction After 
the Procedure 
Time-related freedom from myocardial infarction after the 
coronary bypass and after coronary angioplasty have been 
found to be similar in two studies (73,74). One study (70) found 
an advantage of the bypass operation in this regard. 
D. Freedom From Crossover to Coronary 
Bypass Surgery After Coronary Angioplasty 
Currently available information indicates that, in hetero-
geneous groups of patients undergoing coronary angioplasty. 
freedom from crossover to a subsequent coronary bypass 
operation is 85% to 90% within 1 year of angioplasty, 81% 
within 3 years (72). and 75% to 86% within 5 years 
(69,70,73,76). This crossover, like other end points, is affected 
by risk factors, and a risk factor-adjusted analysis in elderly 
patients showed the freedom from crossover within 5 years 
after coronary angioplasty to be 86%, 78% and 30% in patients 
with one, two and three vessel disease, respectively (73). 
VI. Indications for the Coronary Artery 
Bypass Operation 
A. Introduction 
The coronary artery bypass operation is indicated for the 
relief of symptoms (primarily angina) that are unresponsive 
to medical treatment (or to coronary angioplasty), particu-
larly when the duration of freedom from unfavorable events 
(death. myocardial infarction, return of angina) can with 
reasonable confidence be predicted to be appreciably longer 
than with other forms of treatment. The indications as 
discussed in this section are general, and derived, inasmuch 
as possible. from information about freedom from death 
(survival) and from other unfavorable outcome events after 
the coronary bypass operation (see Section Ill), and about 
the comparative benefit, positive or negative, of this opera-
tion compared with medical treatment (Section IV). How-
ever, a general discussion of indications must of necessity be 
an oversimplification as it can be based on only a few general 
risk factors. This has led to some differences of opinion 
about the treatment classes for the tables. Differences of 
opinion among experts would undoubtedly be very much 
less in individual patients in whom patient-specific predic-
tions and comparisons had been made (see Section X). 
Although only a relatively small amount of pertinent, 
comparative information is available about outcomes after 
coronary angioplasty (Sections V and X), the experience 
with the technique and the prevalence of its use must affect 
current judgments as to indications for the coronary bypass 
operation. Thus assignment of treatment class I indicates 
that the bypass operation has a comparative advantage over 
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medical treatment, and suggests but does not specifically 
indicate that it has an advantage over coronary angioplasty. 
(See Table 1 for description of treatment classes.) Assign-
ment of treatment class II indicates that the comparative 
benefits of the bypass operation relative to medical treat-
ment have not yet been fully defined, and suggests, but does 
not specifically indicate, that the same is true relative to 
coronary angioplasty. Assignment of treatment class III 
indicates that the bypass operation is generally considered 
not to be appropriate, specifically because of a lack of 
demonstrated advantage over medical treatment and, by 
suggestion, over coronary angioplasty. 
The indications for the coronary artery bypass operation 
as discussed in this section are useful for background infor-
mation, and as guides to be modified by more patient-specific 
predictions and comparisons (see Section X) than were 
possible within the confines of this report, and by clinical 
judgment. The adaptability of the patient to the stress and 
morbidity of the coronary bypass operation, and the pa-
tient's other obligations and desires, must also be considered 
in detail by the physician as he makes therapeutic recom-
mendations. The patient, after learning the physician's rec-
ommendations and the risks and benefits of the procedure, 
should make the actual decision. 
Most patients with ischemic heart disease require a number 
of therapeutic recommendations during the lifetime of their 
chronic condition, and the coronary artery bypass operation is 
a treatment that needs to be considered in many of these. The 
recommendation at anyone time to use medical treatment or 
coronary angioplasty rather than the coronary bypass opera-
tion does not preclude the possibility that the bypass operation 
will be advisable at a subsequent time. 
B. Limitations in the Method of Presentation 
The current indications for the coronary artery bypass 
operation are presented in the traditional categories, using 
general statements and tables. The terms used in the tables 
are defined in Appendix E. Inevitably, some combinations in 
tables of this kind are recognized as occurring infrequently. 
This dilemma indicates the advantages of the more patient-
specific predictions and comparisons (Section X) as bases 
for advice to patients. 
The tables could not be made sufficiently detailed to take 
into account certain important but only occasionally pertinent 
situations. As examples, patients with two vessel disease with 
severe proximal stenoses of the left anterior descending and 
left circumflex arteries appear to have the same advantages 
from coronary bypass surgery as do patients with three vessel 
disease (25,77,78). They represent exceptions to the treatment 
class assigned to two vessel disease, and are in the treatment 
class for similar patients with three vessel disease. Severe 
proximal stenosis (:::::90%) of the left anterior descending cor-
onary artery and mUltiple stenoses of this vessel appear to 
impose a poorer outcome with medical treatment and a greater 
comparative advantage of coronary bypass surgery than do 
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other important stenoses of this artery (25). Important left main 
coronary artery disease is defined as a :::::50% reduction of 
luminal diameter, but the prognosis with medical treatment 
worsens and the comparative benefit of coronary bypass sur-
gery increases as the severity of the stenosis increases beyond 
this (29,79). The advantages of the coronary bypass operation 
in patients with left main coronary artery disease may be 
greater in patients with a left dominant system, although this is 
unproved. 
The tables apply only to patients with an ejection fraction 
>0.20. The indications for coronary bypass surgery in pa-
tients with an ejection fraction :::;0.20 require special consid-
eration. First, the possible comparative benefits of the 
coronary bypass operation in patients with an ejection 
fraction between 0.10 and 0.20 have not been fully de-
scribed, although evidence of benefit has been presented 
(80). Second, there appear to be circumstances in which the 
severely reduced ejection fraction is related to ischemic 
myocardial stunning (hibernation) rather than fixed scarring. 
Exercise or rest thallium-20l scintigraphy may be particu-
larly helpful in distinguishing between scar and ischemia in 
such situations. In any event, the coronary bypass operation 
in these circumstances can be considered if it is performed 
under proper conditions, but not as routine therapy. 
C. Timing of the Coronary Bypass Operation 
All surgical procedures, including the coronary bypass 
operation, are most safely and efficiently performed as 
regularly scheduled procedures. With currently available 
information and treatment modalities, and under most cir-
cumstances, the bypass operation should be performed as an 
unscheduled emergency procedure only when there is re-
fractory hemodynamic or ischemic instability. However, in 
the presence of such instability, an unscheduled (emergency) 
coronary bypass operation is indicated no matter what the 
time of day or night. 
D. Indications for the Coronary 
Bypass Operation 
1. Asymptomatic patients. Patients in this category are 
generally well, with no or very mild angina on strenuous 
exertion. The great majority of asymptomatic persons who 
undergo coronary angiography will have had noninvasive 
testing indicative of myocardial ischemia. 
The coronary artery bypass operation is indicated only 
uncommonly for asymptomatic patients with no or mild 
myocardial ischemia with noninvasive stress testing, and 
treatment class I is, in general, limited to patients with 
important left main coronary artery stenosis (81) and those 
with important three vessel disease with severe proximal 
stenosis of a large left anterior descending coronary artery. 
When the noninvasive stress testing in asymptomatic pa-
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Table 6. Treatment Class of the Coronary Artery Bypass 
Operation in Asymptomatic Patients 
CAD None 
Indication Class 
Left Ventricular Dysfunction 
Mild Moderate 
Severe 
(but EF >O.~O) 
A. No or Mild Myocardial Ischemia With Noninvasive Stress Testing 
Left main 
3 vessel 
2 vessel 
I vessel 
II' 
IlIt 
lIlt 
II* 
lIlt 
lIlt 
II 
lIlt 
I 
II 
lIlt 
B. Moderate or Severe Myocardial Ischemia With Noninvasive Stress Testing 
Left main I I 
3 vessel lIt lIt 
2 vessel lIt lIt lIt II:!: 
I vessel IlIt lIlt lit II:!: 
'Class I if there is severe proximal left anterior descending and left 
circumflex coronary artery stenoses. tClass II if there is severe proximal 
stenosis in a large left anterior descending coronary artery. :!:Class I if there is 
severe proximal stenosis in a large left anterior descending coronary artery. 
CAD = coronary artery disease. 
tients indicates moderate or severe ischemia. interventional 
therapy is more often indicated (Table 6). 
2. Patients with chronic stable angina, class I to II. Pa-
tients in this category are clearly symptomatic. but have 
considerable variability in the results of stress testing. the 
type and number of coronary arteries with important steno-
ses and the degree of left ventricular dysfunction. The 
indications for the coronary bypass operation are deter-
mined primarily by circumstances other than the chronic 
stable angina (Table 7). 
Table 7. Treatment Class of the Coronary Artery Bypass 
Operation in Patients With Chronic Stable Class I or II Angina 
CAD None 
Indication Class 
Left Ventricular Dysfunction 
Mild Moderate 
Severe 
(but EF >0.20) 
A. No or Mild Myocardial Ischemia With Noninvasive Stress Testing 
Left main 
3 vessel 
2 vessel 
I vessel 
II' 
II' 
lIlt 
II* 
II' 
lIlt 
II* 
II' 
11* 
11* 
B. Moderate or Severe Myocardial Ischemia With Noninvasive Stress Testing 
Left main 
3 vessel 
2 vessel 
I vessel 
II' 
IlIt 
II' 
lIlt 
II' 
II' 
II' 
11* 
'Class I if there is severe proximal stenosis in a large left anterior 
descending coronary artery. tClass II if there is severe proximal stenosis in a 
large left anterior descending coronary artery. 
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Table 8. Treatment Class of the Coronary Artery Bypass 
Operation in Patients With Chronic Stable Class III or IV Angina 
CAD None 
Indication Class 
Left Ventricular Dysfunction 
Mild Moderate 
Severe 
(but EF >0.20) 
A. No or Mild Myocardial Ischemia With Noninvasive Stress Testing 
Left main 
3 vessel 
2 vessel 
I vessel 
II* 
II* 
II* 
II' 
II' 
II' 
II' 
II' 
B. Moderate or Severe Myocardial Ischemia With Noninvasive Stress Testing 
Left main 
3 vessel 
2 vessel I1* I1* 11* II' 
I vessel II* II* II' II' 
*Class I if there is severe proximal stenosis in a large left anterior 
descending coronary artery. 
3. Patients with chronic stable angina, class III to IV. 
Patients in this category are severely symptomatic and 
usually have one or more severe proximal stenoses. They 
mayor may not undergo noninvasive testing for myocardial 
ischemia. In general, assignment of angina functional class 
III or IV indicates unsatisfactory response to medical treat-
ment. whether the angina is of recent onset or chronic. 
Patients in these categories usually require expedient revas-
cularization. The treatment classes are given in Table 8. but 
it should be noted that patients with angina class III or IV 
rarely have "no or mild myocardial ischemia with noninva-
sive stress testing." 
4. Patients with unstable angina. This discussion in-
cludes but is not limited to patients with myocardial ischemia 
at rest and patients with postinfarction unstable angina. 
Unstable angina is taken as clear evidence of important 
reversible myocardial ischemia. and therefore aggressive 
evaluation and treatment are indicated. 
Emergency or urgent coronary bypass surgery is indi-
cated only when intensive medical management fails to 
relieve the unstable angina. If the unstable state subsides 
within a few days of intense medical management. as is usually 
the case. the patient is studied further and recommendations 
are then made. The unstable angina syndrome predisposes a 
patient to recurrences of the unstable state or myocardial 
infarction. or both. and for this reason is a risk factor for death 
(31). Therefore. the indication for the coronary bypass opera-
tion (treatment class) in any of the previously described cate-
gories into which the patient may fall after study, becomes 
stronger when the unstable angina syndrome has recently (:s2 
months) been present. 
5. Patients with acute myocardial infarction. a. Uncompli-
cated Q wave myocardial infarction. The coronary artery 
bypass operation probably has little place in the management 
of most patients with uncomplicated acute Q wave myocardial 
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infarction, but the matter remains arguable (82-84). However, 
the place of urgent coronary bypass surgery in patients with 
uncomplicated acute myocardial infarction will ultimately be 
determined by its comparative benefit relative to thrombolytic 
therapy and, when needed, coronary angioplasty. 
h. Uncomplicated non-Q wave myocardial infarction. 
Patients with non-Q wave acute myocardial infarction have 
in general the same indications for coronary bypass surgery, 
and for the same reasons, as do patients with unstable or 
postinfarction angina (see previous section). However, care 
must be taken to identify patients with left circumflex 
artery-related infarction and non-Q wave ECG changes, as 
these patients may, in fact, have had a transmural infarction 
and have the prognosis of that condition. 
c. Myocardial infarction with hemodynamic deterioration. 
Acute hemodynamic deterioration in association with myo-
cardial infarction is an emergency, but optimal therapy has 
not been fully defined. The intraaortic balloon pump is often 
highly effective, but delay in direct interventional therapy 
when hemodynamic deterioration continues may be disad-
vantageous. Coronary artery bypass surgery, with myocar-
dial management tailored to patients with acute infarction 
and according to present knowledge, gives evidence of 
providing a considerably improved outcome over noninter-
ventional methods of therapy in this setting (20). 
6. Acute complications of coronary angioplasty. Only 
when there is coexisting acute hemodynamic deterioration is 
coronary artery bypass surgery performed immediately after 
unsuccessful coronary angioplasty associated with increased 
risk (6). When this circumstance develops in the interven-
tional catheterization laboratory, and is not promptly re-
lieved by percutaneous techniques, urgent coronary bypass 
surgery is indicated. The techniques of myocardial manage-
ment described for use in patients with acute myocardial 
infarction in cardiogenic shock are applicable. 
When the patient's condition is good after a complication 
of coronary angioplasty, the indications for coronary bypass 
surgery are not urgent, and the treatment classes previously 
described apply. 
7. Previous coronary bypass surgery. Evidence of return of 
important myocardial ischemia should be required for consid-
eration of another coronary bypass operation in a patient who 
has already undergone such a procedure. Cineangiography is a 
requisite for decision-making. If the offending disease is local-
ized and in the native circulation or if the offending disease is in 
the bypassing conduits, and distal native vessels are seen to be 
open, another coronary bypass operation is usually indicated. 
When a repeat bypass operation is recommended, the indica-
tion should be strong and the patient's general health otherwise 
good, in view of the increased risks and uncertainties in the 
second operation (see Section III). 
E. Theoretically Ideal Indication 
Theoretically, the coronary bypass operation performed 
in an optimal manner at the appropriate time should have not 
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only an appreciable comparative benefit over alternative 
forms of therapy, but also a high event-free survival for a 
prolonged period (:2:15 years). However, a high event-free 
survival for :2: 15 years is immutably denied by important 
fixed (at rest) left ventricular dysfunction at the time of the 
coronary bypass operation, even though the greatest com-
parative benefit is achieved in this situation. Thus, ideally 
the coronary bypass operation should be performed while 
left ventricular function remains normal or minimally im-
paired. However, performing the operation under these 
circumstances, rather than later in the life history of patients 
with ischemic heart disease. is discouraged by the current 
limitation on the duration of the operation's favorable effect 
imposed by progression of the atherosclerotic disease in the 
native coronary arteries and in the bypassing conduits. This 
limitation leads to the currently appropriate tendency to 
defer the operation for as long as is possible, although such 
a strategy often results in the development of important left 
ventricular dysfunction at rest. 
The challenge for the future is to make safe the delay of 
the coronary bypass operation until extensive three vessel 
disease develops, by learning to predict the imminence of an 
acute ischemic syndrome such as myocardial infarction and 
resultant loss of normal left ventricular function. There are 
strong suggestions that alterations in the state (milieu) in the 
patient (instability of coronary atherosclerotic plaques [85], 
alterations in the thrombotic and thrombolytic mechanisms 
[86]) precede such an event, and progress is being made in 
identifying these alterations (87). Once identified, the alter-
ations may possibly be reversed by medical treatment, and 
the infarction prevented and left ventricular function main-
tained. If such treatment is successful. the coronary bypass 
operation can then be deferred until extensive three vessel 
disease develops (if it does). 
F. Contraindications to the Coronary 
Bypass Operation 
A contraindication to the coronary bypass operation is 
absence of any open major artery :2: 1 mm in diameter beyond 
the obstructing lesion. This contraindication no doubt oc-
curs, but it is rare. Unless high quality cineangiograms have 
been made, this contraindication may be falsely diagnosed. 
Complete absence of viable myocardium in the area 
supplied by the stenosed or obstructed arteries is a contrain-
dication to the coronary bypass operation, but this also is 
rare in the absence of an aneurysm involving the entire area. 
Coexisting severe non cardiac conditions with a poor 
prognosis are relative contraindications to the coronary 
artery bypass operation. Extreme debility, mental and emo-
tional deterioration and multiple system disease may con-
traindicate the operation. Older age in itself is not a contrain-
dication to the bypass operation (see Section IV), but 
hospital morbidity and mortality and the prevalence of 
peri operative stroke are higher in patients older than about 
75 years of age (88,89). 
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VII. Long-Term Management After the 
Coronary Bypass Operation 
The clinical recognition of coronary artery disease suffi-
cient to require the coronary bypass operation commits the 
patient and his or her physicians to a comprehensive and 
long-term plan for counseling, individualized medical inter-
ventions and monitoring and general medical care. The 
long-term treatment plan attempts to facilitate the complete 
recovery of the patient from the operation, promote early 
and long-term patency of grafts, control the risk factors for 
arteriosclerosis and diagnose and manage recurrent myocar-
dial ischemia, should it occur. 
A. Facilitation of Complete Recovery From the 
Coronary Bypass Operation 
Cessation of cigarette smoking is a primary objective in 
preoperative and postoperative care. The patient should be 
informed of the importance of this both before and early 
after the operation. 
The long-term treatment plan begins as soon as possible 
after the bypass operation, which may be as early as the 3rd 
or 4th postoperative day. It consists in large part of arranging 
the patient's orderly transfer from the routines of in-hospital 
care to those in an ambulatory setting. Care is taken that 
administration of needed medications begun in the hospital is 
continued for the appropriate period after hospital discharge. 
The incidence of ventricular and atrial arrhythmias dimin-
ishes rapidly in the early in-hospital phase of recovery. but 
as many as 15% of patients may continue to experience them 
until the time of hospital discharge. These patients usually 
require only short-term (4 to 8 weeks) postdischarge treat-
ment for the arrhythmia. Arrhythmias that persist after this 
time require special investigation. 
The patient with treated hypertension before surgery 
frequently does not require the use of antihypertensive 
agents during the early convalescence. Therefore, it is 
appropriate not to prescribe these agents routinely early 
after operation, but to await a specific indication. 
At the time of the early postdischarge evaluation, issues 
related to convalescence from the operation should be 
addressed with the patient and family. as well as any specific 
problems that may have been encountered in the hospital. 
Commonly, a chest roentgenogram. rest ECG. complete 
blood count and a biochemical profile are obtained at that 
time. Thereafter. one physician should assume the respon-
sibility for long-term management, to assure continuity of 
care and constancy of goals. Whether the physician is a 
family practitioner, an internist or cardiologist is secondary 
in importance to his or her commitment, skill. availability for 
long-term care and acceptance by the patient. 
During the 1st 6 to 8 weeks of convalescence from the 
coronary bypass operation, patients commonly have a poor 
appetite, insomnia, emotional depression, visual or memory 
or intellectual deficits, loss of sexual ability. lack of desire to 
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return to work. and other potentially disabling manifesta-
tions of the postoperative state. Studies have documented 
the transient nature of most of these phenomena. Therefore, 
for the patient's well-being and eventual complete recovery, 
the responsible physician should reassure the patient as to 
the likely transient nature of these disturbances, and help 
him or her to return to usual activities as rapidly as possible. 
During this period. excessive medications may predispose to 
symptoms. and minimization of medications for various 
specific indications is frequently beneficial. 
A program of daily exercise should be started as soon as the 
patient leaves the hospital, and should emphasize regular 
walking for progressively longer periods of time. These pro-
grams should be individualized, based primarily on knowledge 
of the completeness of the operation and the left ventricular 
function. Formal programs of rehabilitation can be helpful in 
guiding some patients through this resumption of physical 
activity. Ultimately and unless specifically contraindicated, 
patients should be encouraged to obtain some form of regular 
physical activity on a daily basis and to increase this over the 
months after operation. Patients who were active and gainfully 
employed before surgery are urged to return to full activity and 
employment as soon as possible and, except in unusual circum-
stances, no later than 2 to 3 months after surgery. 
B. Promotion of Patency of Grafts 
The advantage of antiplatelet agents in promoting patency 
of vein grafts during the I st postoperative year is well 
established (90-93). The precise protocol and the appropri-
ate length of use of the drugs remain arguable, although the 
Veterans Administration randomized trial (92,93) has shown 
aspirin alone, in a dose of 325 mg daily beginning 6 h after 
operation. to be as effective as any other protocol. The 
aspirin (325 mg) should be started 6 h after the operation via 
the nasogastric tube which is then clamped for 1.5 h, and 
should thereafter be given in a similar dose once daily for at 
least I full year. Such a regimen is most effective early 
postoperatively and in vessels <2 mm in diameter (93,94). 
Patency of the vein grafts for more than I year after 
bypass surgery may be enhanced by control of the risk 
factors for arteriosclerosis. 
C. Control of the Risk Factors 
for Arteriosclerosis 
Once the patient has recovered from the operation, he or 
she should be counseled about the importance of maintaining 
an appropriate body weight with caloric restriction if neces-
sary. and optimally low blood lipid levels, control of hyper-
tension and cessation of smoking. These features of care are 
important because elevated blood lipids have been shown to 
be an important risk factor for the atherosclerotic disease in 
saphenous vein bypass grafts (56,95-98) and because aggres-
sive dietary and pharmacologic control of the serum choles-
terol has been shown to retard the progression of vein graft 
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atherosclerosis (99). Specific types and combinations of 
pharmacologic intervention should depend on the type of 
lipid abnormality exhibited by the patient. 
D. Diagnosis and Management of Recurrent 
Myocardial Ischemia 
Electrocardiographic stress testing may be useful 6 weeks 
to 6 months after operation, particularly in patients in whom 
preoperative ischemia was "silent." Exercise stress testing 
is also valuable in identifying patients who have two or more 
ungrafted vessels or who may have had early graft closure 
(100,101). When a postoperative patient with an initially nega-
tive postoperative treadmill test later develops a positive test, it 
is usually a reliable indicator of progressive ischemia due to 
either graft closure or progression of disease in the native 
circulation (102). In addition, myocardial perfusion imaging 
with either exercise stress or dipyridamole infusion can en-
hance the detection of recurrent myocardial ischemia in pa-
tients who have ST-T wave abnormalities at rest. 
Angina is likely to recur at some time after the bypass 
operation (see Section III). Although an argument can be made 
for the prophylactic use of nitrates, beta receptor blocking or 
calcium channel blocking agents when revascularization is 
incomplete, it is more rational to avoid the routine use of these 
agents until the return of ischemia has been documented. Once 
angina recurs and is persistent, or noninvasive stress testing 
yields positive results, or both, coronary arteriography and 
consideration offurther interventional therapy are indicated. If 
the patient is elderly or has serious coexisting diseases, delay 
until symptoms become severe and unresponsive to medical 
therapy may be warranted. 
VIII. Organization of a Cardiac Surgical 
Program for the Coronary Artery Bypass 
Operation (personnel, facilities, quality of 
care, case loads) 
A. Personnel 
All personnel involved in the management of patients 
undergoing the coronary artery bypass operation must un-
derstand and respect the need for leadership, mutual re-
spect, collegiality and communication among the various 
professionals providing care to the patient. These lead to 
superb care without unnecessary tests and interventions or 
redundancy of effort, and thus without unnecessary escala-
tion of costs and fragmentation of care. 
1. Physicians. The coordinated expertise of many profes-
sionals is required to ensure optimal outcomes after coro-
nary artery bypass surgery. 
a. The cardiac surgeon. This physician should have 
primary responsibility for the patient during the operation 
and during the 1st 24 to 72 h after the operation, and longer 
if early convalescence is delayed. During this period, the 
surgeon should call on the knowledge and skills of a cardi-
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ologist, who should also be monitoring the patient's course 
whenever this is advantageous to the patient. The surgeon 
should follow the patient closely during the remainder of the 
hospital stay and the first few days of outpatient care, even 
though institutional practice may place primary responsibil-
ity after the first 24 to 72 h with the cardiologist. 
Preoperatively, the surgeon should evaluate the patient 
and records in detail. Except in absolute emergencies, a 
preoperative written note by the surgeon on the patient's 
record should be mandatory. The note should describe the 
comparative benefits and risks of the coronary bypass oper-
ation (the bases for informed consent by the patient) and the 
surgeon's opinion and recommendations. 
The cardiac surgeon should in most instances be certified by 
the American Board of Thoracic Surgery or an equivalent 
certifying body in another country. The surgeon should have a 
thorough understanding of basic medical and surgical knowl-
edge and particular information about cardiac surgical tech-
niques, cardiopulmonary bypass and methods of myocardial 
management. The surgeon should have demonstrated, in addi-
tion, clinical competence in the preoperative evaluation of a 
potential candidate for surgery (including the interpretation of 
coronary cineangiograms and catheterization data), the surgi-
cal procedure itself and postoperative care (3,103). 
A hospital coronary artery bypass surgery program should 
have as a minimum two qualified cardiac surgeons (103). For 
optimal outcomes, the practice of these cardiac surgeons 
should be concentrated in a single institution, in order to 
promote familiarization with its facilities, procedures, consul-
tative and nursing resources and to ensure availability. 
h. Surgical assistants. Under most circumstances, the 
coronary bypass operation, including removal and prepara-
tion of saphenous veins, can be well performed by a single 
surgeon and two assistants. The first assistant should be 
either a resident or other physician or a specially trained 
surgeon's assistant. Use of surgeon's assistants should have 
a favorable impact on procedural costs while maintaining 
high standards of care (see Section IX). 
c. Anesthesiologists. Anesthesiologists assigned to cardiac 
surgery should have complete familiarity with the preopera-
tive. intraoperative and early postoperative requirements of 
cardiac surgery and be able to participate as part of an efficient 
and coordinated team. This usually requires subspecialization 
by the anesthesiologist. Appropriate patient care as well as the 
allaying of concerns of the patient and family require a consul-
tative visit to the patient by the anesthesiologist on the day 
before the operation. except in emergency situations. In the 
intensive care unit, the anesthesiologist's knowledge and skills 
in the management of the respiratory system early postopera-
tively should be of particular benefit. 
Cardiac anesthesiologists should in most instances be cer-
tified by the American Board of Anesthesiology or equivalent 
certifying body in another country and should have special 
training in the anesthetic and supportive requirements of open 
heart surgery. They should have skill and experience in the 
induction of anesthesia and intraoperative management of the 
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patient with myocardial ischemia, unstable angina, evolving 
myocardial infarction, cardiac arrhythmias and heart failure. 
They should have competence in the monitoring and manage-
ment of the patient's cardiorespiratory systems and of electro-
lyte and coagulation abnormalities. 
d. Cardiologists. Optimally, the patient's cardiologist 
should follow the patient's course in the intensive care unit. 
even though primary responsibility in the 1st 24 to 72 h is with 
the surgeon. As the patient leaves the intensive care unit, the 
primary responsibility may shift to the cardiologist. who should 
call on the knowledge and skills of the surgeon as necessary. 
Cardiologists participating in cardiac surgical programs 
should in most instances be diplomates of the SUbspecialty 
board for cardiovascular diseases of the American Board of 
Internal Medicine, or certified by an equivalent certifying 
body in another country. They should have experience in all 
aspects of the care of patients with coronary artery disease. 
Specialized skills in invasive cardiology, electrophysiology, 
echocardiography and cardiac pacing should be available 
within the institution. 
e. Other physician specialists. Institutional practices 
may provide for concentration of effort in the intensive care 
unit by partiCUlarly qualified surgeons, anesthesiologists, 
cardiologists or others. 
Coronary bypass surgery is most successful when there is 
cooperation, coordination and effective communication among 
multiple disciplines, without fragmentation of care and without 
unnecessary use of consultants. All the specialists and facilities 
of a general hospital may on occasion be needed, and these 
services should be available on a 24 h basis. 
2. Nursing personnel. 
a. Operating room. Generally. one surgical nurse or 
technician and a circulating nurse or technician are required 
for the performance of coronary artery bypass surgery. Just 
as is true of the other members of the operating room team, 
the surgical nurses should be especially qualified in cardiac 
surgical nursing and be prepared to be part of an efficient 
team under the direction of the surgeon. This usually re-
quires commitment of these nurses to cardiac surgery. 
The open heart nursing team also requires a director 
responsible for scheduling, training and quality of the nurs-
ing services for the cardiac operating rooms. 
b. Intensive care units. Cardiac surgery intensive care 
nursing requires specialized training, to develop the theoret-
ical knowledge and clinical skills required for the intensive 
care of cardiac surgical patients. Nurse to patient ratios 
should be I: I or 1:2 in the early postoperative hours and until 
the morning after the day of surgery. recognizing that 
exceptions to this may be possible with extensive automa-
tion and well developed and tested protocols. Staffing levels 
should be adequate 24 hours a day. 
Active coordination and mutual respect among nursing 
personnel, cardiac surgeons. cardiac anesthesiologists. cardi-
ologists and, when required. consultants is essential in the 
intensive environment of the cardiac surgery intensive care 
unit. 
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c. Pre- and postintensive in-hospital care. Before the op-
eration. an expanded explanation of the diagnostic and thera-
peutic procedures by the nurse can allay fears and facilitate 
understanding and cooperation. Nursing personnel in the areas 
to which the patient is transferred after the intensive care unit 
should be able to distinguish between minimally dangerous and 
potentially highly dangerous cardiac arrhythmias. They should 
be able to initiate resuscitative measures, and recognize the 
indications for these. They should be knowledgeable about the 
postbypass surgery treatment protocols and be able to imple-
ment them skillfully. The nursing personnel should be support-
ive of the patient in all ways and help the patient to begin the 
process of convalescence. 
Instruction of the patient and family by the nursing 
personnel. at a time when the patient is most receptive 
regarding risk factor modification. may favorably influence 
long-term outcomes. Nursing personnel assignments should 
be adequate to meet these goals, and well designed programs 
can be cost effective. 
3. Perfusionists. Trained perfusionists prepare, maintain 
and operate the pump-oxygenator and related equipment 
during the coronary artery bypass operation and during its 
uncommon use before or early after cardiac surgery. They 
should work under the direct supervision of a physician or 
physicians expert in all matters relating to cardiopulmonary 
bypass. Nearly always this is the cardiac surgeon or cardiac 
anesthesiologist or. preferably. an interactive team com-
posed of both. Working under the direction of the cardiac 
surgeon or anesthesiologist. or both. the perfusionist may 
also be responsible for the operation of red blood cell-saving 
procedures and circulatory assist devices. 
Because the duties of perfusionists vary widely among 
institutions and because the perfusionist should be part of a 
well coordinated physician-nursing-perfusionist team. each 
perfusionist should concentrate his or her practice in one 
hospital. 
Perfusionists should be graduates of an approved perfu-
sion technology training program or have equivalent training 
(104). 
4. Other personnel. An active cardiac surgical program 
will usually require the support of a full complement of 
hospital professionals. These include pharmacists, dieti-
cians. respiratory therapists. social workers and physical 
therapists with cardiac rehabilitation skills. 
B. Facilities 
1. Cardiac operating rooms. The requisite space and 
equipment of an operating room for open heart surgery have 
been described previously (3). The operating room should be 
600 to 800 square feet (55 to 75 m2) in size, have adequate 
electrical grounding, oxygen and vacuum supply, proper 
illumination. and be capable of supporting the technical 
equipment utilized in cardiopulmonary bypass, including the 
pump-oxygenators. heat exchange equipment, cell saver, 
anesthetic apparatus and assist devices. 
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The availability and staffing of more than one cardiac 
operating room per surgeon considerably enhances the effi-
ciency and productivity of a cardiac surgical program. 
2. Cardiac surgery intensive care unit. A fully staffed and 
equipped cardiac surgery intensive care unit is required. It is 
questionable whether the needs of the cardiac surgical 
patient can be appropriately met in a general intensive care 
unit. The number of available intensive care unit beds should 
be approximately half the number of open heart operations 
performed per week. The unit should be under the direction 
of a qualified physician, optimally the cardiac surgeon, and 
should have a unit nurse director. It should have typical 
intensive care unit capabilities, including continuous electro-
cardiographic and hemodynamic monitoring and recording, 
and equipment and personnel for full ventilatory support. 
The unit design should provide for direct visual assess-
ment of the patients from the nursing stations. This unit 
should be in relatively close proximity to the operating 
room. Several patient areas should be large enough to 
accommodate mUltiple life support systems, such as in-
traaortic balloon pumps, ventricular and total circulatory 
assist devices and hemodialysis machines. 
Portable chest roentgenographs should be available 24 
hours a day. The unit should be able to obtain immediately 
arterial blood gas analyses, serum electrolyte measurements 
and certain other laboratory tests, and should be informed of 
the results as soon as they are available. 
Most patients undergoing an elective coronary bypass op-
eration are able to be transferred out of the intensive care unit 
the morning after surgery. Early transfer reduces delays and 
costs and ensures optimal utilization of expensive facilities. 
3. Postintensive care ("stepdown facility"). Early safe 
transfer from the intensive care unit is facilitated by the 
availability of radiotelemetry for ECG monitoring in the area 
to which the patient is transferred. This is preferably a 
standard bed area, which may have both immediately pre-
operative cardiac patients as well as postoperative patients. 
This latter group should be in the majority. 
Radiotelemetry allows rapid identification of important 
arrhythmias. Ideally, the telemetry should be monitored 24 h 
a day by technicians under the immediate direction of the 
nursing staff and under the overall direction of a cardiologist 
or cardiac surgeon. 
4. Catheterization and angiographic facility. Coronary 
arteriography of diagnostic quality is a requisite to the 
performance of coronary artery bypass surgery, and must be 
available in any hospital with a cardiac surgery program. The 
optimal resources and facilities for performing cardiac cath-
eterization and coronary angiography have been summa-
rized previously (105,106). 
5. Ambulatory pre- and postoperative care facility. Be-
fore surgery, it may be possible to identify some preopera-
tive low risk patients who can be admitted to the hospital 
early on the morning of surgery without increased risk and 
with apparent institutional cost savings (107). However, it is 
not clear that such a strategy is advantageous to most 
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patients or is cost-effective when all aspects of the patient 
care program are considered. 
Early discharge of the patient from the hospital (on 
postoperative day 5 or 6) has been shown to be advantageous 
when provisions have been made for continuing close sur-
veillance for the first 3 or 4 postdischarge days (l08). This is 
made most effective by the availability of a well staffed and 
well equipped ambulatory patient care facility in which 
needed observation and tests can be performed. 
C. Quality of Care 
A cardiac surgery program should include regular. fre-
quent and formal review in conference of all deaths and 
major complications. This should be attended by cardiac 
surgeons, cardiologists and pathologists, as well as residents 
and students in teaching institutions. Quality assurance 
programs. in-service educational programs and mUltiple lay-
ers of in-house administrative reports frequently add only 
expense. inconvenience and undue consumption of time to 
that which can be accomplished by intense. conscientious 
and regular review of deaths and complications by the 
professional staff. 
D. Case Loads 
1. Historical information. Recommendations regarding 
minimal institutional levels of use for open heart surgery (200 
to 300 cases annually) were first published by the Inter-
Society Commission for Heart Disease Resources in 1972 
(3). Approximately one-half of the hospitals with open heart 
surgery programs in 1980 did not meet these lowest recom-
mended case load volumes (109,110). Similar minimal annual 
case load recommendations specifically for coronary bypass 
surgery were proposed by an American College of Surgeons 
subcommittee in 1984 (103). The percentage of hospitals 
currently performing less than the minimal annual procedure 
volume appears to remain about the same despite the large 
increase in the number of coronary artery bypass operations 
performed, because of the extensive proliferation of hospi-
tals with coronary bypass programs (111). 
2. Recommendations. In general, a yearly minimum of 
200 to 300 open heart operations, the majority of which are 
coronary artery bypass operations. should be performed in 
hospitals (institutions) caring for patients requiring surgery 
for ischemic heart disease. Hospitals in large and sparsely 
populated geographic areas may require a different. specifi-
cally derived recommendation. 
In general, a yearly minimum of 100 to 150 open heart 
operations, the majority of which are coronary artery bypass 
operations, should be performed by each surgeon caring for 
patients with ischemic heart disease. Again. surgeons in 
large and sparsely populated geographic areas may require a 
different, specifically derived recommendation. 
These recommendations about case load are general and 
should be applied with the knowledge that several reports 
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attest that it is possible for a particular low volume hospital 
or surgical group or surgeon to have good results (112-114). 
3. Bases for recommendations. The issues, with respect 
to case load, are quality and appropriateness of the coronary 
bypass operation (at present. judged only by hospital mor-
tality and morbidity), patient access. cost-effectiveness and 
institutional morale and costs. 
a. Quality and appropriateness. A relation between car-
diac surgical volume and mortality after coronary bypass 
surgery was suggested in 1979 from comparison of outcomes 
between hospitals with <200 coronary bypass operations 
annually (5.7% mortality) and hospitals with >200 annual 
coronary bypass operations (3.4% mortality) (115). These 
institutional volume effects may be even greater for emer-
gency coronary bypass operations (Ill). 
The most recent and thorough examinations of the relation 
of institutional and surgeon volume to hospital mortality are the 
reports from the Depaltment of Health of the state of New 
York (IOJ. 102). In that state in 1989, hospital mortality for the 
coronary bypass operation (n = 12.448) was 3.6W7r. The 
relation between volume (surgeon and hospital) and outcome 
suggests that the statewide mortality would have been 2.677c 
had all operations been performed by surgeons doing at least 
180 cardiac operations per year in hospitals in which at least 
700 cardiac operations were performed yearly (Table 9). 
The predicted effect of a criterion of 300 cases per year for 
an institution and 150 for a surgeon is in Table 10. Noteworthy 
is the suggestion that had this criterion been in place. the 
hospital mortality for the state of New York as a whole would 
have been 3.19%, lower than the actual one of 3.68SIr. but 
higher than the 2.67% predicted had criteria of 2700 and 2180 
for institutions and surgeons been used. These analyses are 
supported by a multivariable risk factor analysis. in which 
decreasing surgeon and institutional volumes (as continuous 
variables) were risk factors for higher hospital mortality 
throughout the range of cases'year- I (116). Neither finding 
could be accounted for by chance alone. hut the finding was 
even more secure in the case of surgeons (p < 0.00 I) than in the 
case of institutions (p = 0.04). It is noteworthy. however, that 
the differences are small. 
Hannan and colleagues (117) (Hannan EL. Personal com-
munication, 1990) also found that ~ome institutions with 
small volumes had particularly unfavorable risk-adjusted 
hospital mortality rates compared with those of other low 
volume hospitals; and some high volume institutions had 
risk-adjusted mortality rates considerably higher than those 
of other high volume hospitals. 
The relation of the appropriateness of the coronary 
bypass operation to institutional and surgeon volume has not 
been determined. 
h. Patient access. A recommendation against low volume 
cardiac surgery programs raises issues of patient access and the 
large nonreimbursable costs incurred by the patient and family 
when an individual undergoes the coronary bypass operation in 
a remote institution. However. an analysis of market and 
regulatory influences on the availahility of coronary bypass 
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Table 9. The Relation of Risk-Adjusted Hospital Mortality 
After Coronary Artery Bypass Grafting to Institution and 
Surgeon Cardiac Surgery Volumes in the State of New York 
in 1989 (n = 12,448)* 
Surgeon Volume 
Hospital Volume (cases·institution 
(cases'surgeon I) 28-199 200-699 
<00 13.260{ 9.67'7r 
60-99 4.69~t, 4.92'7r 
1011-179 5.48';' 4.20clr 
21XO 6.06'7r 3.13'1r 
563 
I) 
dOO 
5.04'7r 
4.63'7r 
3.R5'7r 
2.67'7r 
*AII volumes refer to all cardiac surgery cases. not just the coronary bypass 
operation. Statewide mortality (1989) was 3.680{. Thus a risk-adjusted (for 
patient-specific incremental risk factors) mortality rate indicates> 3.68'7r less 
good performance than in New York State as a whole: a rate <3.6870 indicates 
better performance. In this table and table 10. the percents refer to risk-adjusted 
hospital mortality. Adapted with permission from Hannan et al. (116). 
surgery in hospitals in the United States found that the larger 
the number of local hospitals, the more likely it will be that a 
majority of the hospitals will offer the coronary bypass opera-
tion. and SO'7r of low volume hospitals «200 cases per year) 
had one or more nearby hospitals with a surgical program that 
included the coronary bypass operation (liS). 
Large geographic areas that are sparsely populated have a 
particular problem of access. These areas should require 
greater flexibility of case load guidelines. although referral of 
cases to large centers outside their areas should be considered. 
c. Cost-effectil·eness. Costs per cardiac surgery proce-
dure have been shown to increase with decrease in institu-
tional cardiac surgical volumes (119). The relative costs were 
particularly great when the volume was 100 cases per year or 
less (120), Also. larger institutional volumes of cardiac 
surgery correlate not only with a lower mortality rate, but 
also are associated with a shorter length of hospital stay 
(Ill). and thus lower costs per case can be expected. 
d. institutional morale and costs. The proliferation of 
small cardiac surgery programs tends to result in the referral 
of high risk patients (with poor outcomes. frequent compli-
cations and longer lengths of stay in intensive care units and 
in the hospital) to centers. This tends to concentrate low risk 
patients in smaller programs. This disparity of case mix can 
result not only in morale problems among the personnel in 
the larger programs. but also in financial burdens for these 
Table 10. The Relation of Risk-Adjusted Hospital Mortality 
for the Coronary Artery Bypass Operation to Criteria 
of 300 Institution and 150 Surgeon Cardiac Surgical Cases 
Per Year (total'year- I )* 
Hospital Volume 
(cases.institution -I) 
Surgeon Volume 
(cases',urgeon I) 28-299 dOO 
1-149 
2150 
5.63'7r 
3.48'7r 
5.0170 
3.19'7r 
'Prepared from a study in the state of New York in 1989 (Hannan EL. 
Perq'nal communication. 1990). 
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centers because of a larger cost per case. Nonetheless, the 
transfer of patients with complex problems to experienced 
centers is often in the best interests of these patients. 
4. Precautions and pitfalls. Possibly, the correlation be-
tween high volume and superior results (in terms of hospital 
mortality) is not due to the high volume itself, but rather to 
the possibility that a surgeon or institution of high quality 
tends to attract more patients. A high volume institution 
generally finds it easier to attract highly competent surgeons 
and other personnel than do low volume institutions. 
Some studies of the relation between volume and hospital 
mortality have not taken into account differing prevalences 
of patient risk factors. This can lead to erroneous and unfair 
conclusions and practices. It is hoped that the exemplary 
recent reports by Hannan and colleagues (116,117) from the 
state of New York, based in part on the important work done 
previously by Parsonnet and colleagues (121), will stimulate 
the further development of properly performed studies and 
public reports in these areas. 
IX. Costs and Charges of the Coronary 
Artery Bypass Operation 
A. Background 
The cost of health care in the United States has been 
rising and reached $548 billion in 1988. This figure is twice 
the amount spent in 1980 and is 11% of the gross national 
product. The charges for the coronary bypass operation 
have been considered to be a major factor in these rising 
costs of health care. 
Between 1981 and 1986, the number of coronary bypass 
procedures increased from 159,000 to 284,000, and Medicare 
beneficiaries accounted for> 25% of this volume. Estimates 
from Medicare have indicated that 63,000 hospital bills were 
processed in 1985 related to the coronary bypass operation, 
resulting in >$1.5 billion in charges to Medicare (122). 
These facts are not necessarily evidence of inappropriate 
use of the coronary bypass operation. Furthermore, if an 
average current total charge of about $40,000 (for the bypass 
operation, hospitalization, and so forth) is assumed for 
300,000 coronary bypass procedures per year, the total 
charges would be about $12 billion, or about 2% of the total 
cost of health care in the United States. 
B. Risk Factors for Higher Charges 
The most often noted risk factor for higher charges is 
geographic location. In 1982 to 1983, the average total charge 
nationally for the coronary bypass operation and associated 
procedures and hospitalization was $21,800. The highest 
average charge, $29,500, was in the Pacific region, while the 
lowest, $18,300, was in the East South Central region (123). 
By 1986 the average charge was $30,430, and ranged from 
almost $40,000 in the Pacific region to $27,000 in the West 
North Central states. 
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Some risk factors for higher charges in general have been 
identified. However, at least some of those identified are 
actually surrogates of more fundamental risk factors. As ex-
amples, the occurrence of sternal wound infection has been 
reported to add an average of $41 ,559 to the hospital bill, while 
respiratory failure added $28,756 and left ventricular failure 
added $5,186 (124). A valid argument could be made for 
considering diabetes, obesity or inadequate operating room 
techniques as the fundamental risk factors for the added 
charges associated with sternal wound infection. Preoperative 
chronic obstructive lung disease, the damaging effects of car-
diopUlmonary bypass and inadequate effort for early extuba-
tion and discharge from the intensive care unit are probably the 
fundamental risk factors for the added charges associated with 
respiratory failure. Preoperative left ventricular dysfunction, 
and inadequate myocardial management during the coronary 
bypass operation, may be the fundamental risk factors associ-
ated with the added charges attributed to left ventricular 
failure. These considerations emphasize the increasing preva-
lence and importance of risk factors in patients currently 
undergoing the coronary bypass operation, and the need for 
strong research and education programs designed to reduce 
costs by improving patient care protocols. 
Longer hospital stay after the coronary bypass operation 
is generally associated with higher charges, and risk factors 
for longer stay are generally, therefore, also risk factors for 
higher charges. Older patients, women, patients requiring 
emergency surgery and those with severe angina, diabetes, 
renal dysfunction or low ejection fraction have been shown 
to be more likely to have complications and therefore to 
require a long hospital stay (125). Although the charges 
associated with these risk factors may gradually be reduced 
by new knowledge generated by research and by education, 
many of the risk factors are probably for the moment 
immutable. Nonetheless, it is many of these very patients 
who receive the greatest comparative benefit from the cor-
onary bypass operation (see Sections IV and V). 
High hospital mortality may also be associated with 
increased total charges, in spite of short hospital stays, 
because of the unusually large number of personnel and 
devices used in the perioperative period in many patients 
who die. The importance of these is clear from the fact that 
many deaths after the coronary bypass operation occur early 
postoperatively (in one institution [Kirklin JW, Blackstone 
EH. Personal communication, 1990] 30% occurred within 
the first 48 postoperative hours, and 50% within 9 days). 
Most of the patients who die early postoperatively are 
seriously ill from the moment the operation has been com-
pleted, and during the interval between operation and death 
are intensively treated. The interventions often include the 
use of intraaortic balloon pumping, extracorporeal mem-
brane oxygenation, ventricular assist devices, prolonged 
respiratory support, hemodialysis and extensive pharmaco-
logic intervention. This, and the associated personnel re-
quirements, all emphasize the economic as well as individual 
importance of obtaining the lowest possible hospital mortal-
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ity and morbidity rates consistent with continuing to perform 
the coronary bypass operation on all patients in whom it is 
appropriate. 
C. Precautions and Pitfalls 
Identifying the cost of the coronary bypass operation, and 
comparing it with those of alternative forms of treatment. 
would appear to be a straightforward process. The charges 
for each hospital stay and professional contact could be 
gathered from computerized bills. These charges could then 
be totaled for some stated period of time and compared with 
those for coronary angioplasty, noninterventional medical 
treatment and other alternative forms of treatment. They 
could also then be compared according to geographic region, 
type and size of hospitals, method of practice (individual 
versus group practice), or method of billing (itemized versus 
global fee). 
However, the variability in charges made for the coro-
nary bypass procedure reflects both variability in actual 
costs, and variability in the proportion of the charge that 
comes from overhead and related factors. This is because 
the charge includes 1) the actual cost of performing the 
procedure, 2) the overhead for supporting those hospital or 
professional services whose actual costs exceed the reim-
bursement, 3) the overhead for meeting ongoing and often 
unrelated costs that must· be shared among users of the 
institution, and 4) the overhead to cover projected costs of 
future expansion and equipment purchases in general. The 
differences between charges and costs, determined by a 
variety of factors, must be understood in assessing the 
financial impact of reducing or increasing the number of 
cardiac procedures performed. 
Additionally, any consideration of restricting the use of 
the coronary bypass operation in patients in whom it is 
indicated must take into account other results of such 
restrictions. Patient disability will become greater. The 
accumulated costs of medication, recurrent hospital stays 
and subsequent myocardial infarctions and congestive heart 
failure will increase and may become greater than those of 
the coronary bypass operation. 
In summary, any deliberate reduction in the number of 
coronary bypass procedures by rationing, in order to reduce 
costs, needs to consider the other fiscal. as well as human, 
effects of such a program. 
D. Recommendations 
A concerted effort should be made by the medical pro-
fession to reduce the costs of the coronary bypass operation 
without reducing its benefits. Since it is a commonly per-
formed operation about which a great deal is now known, 
areas in which significant cost reductions can be made 
without sacrifice in quality should be identifiable. Unneces-
sary components of care relating to the coronary bypass 
operation should be eliminated, and one mechanism for this 
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is the forming of appropriate guidelines and indications for 
the coronary bypass operation. The difficulties of accom-
plishing these eliminations are recognized, and include the 
threat to the survival of some institutions and to the liveli-
hood of some individuals in some specialties and areas of 
servIce. 
The recommendations are as follows: 
1. This report has described the variables (risk factors) 
upon which the recommendation for one or another form of 
therapy can appropriately be made (Sections IV, V, VI and 
X). Examinations and tests that do not relate directly to 
identifying the values of these variables (risk factors) should 
not be performed as service items, although they may be 
necessary in research protocols. 
2. Redundancy in the provision of services within an 
institution should be avoided. 
3. Properly trained surgeon's assistants, rather than fully 
qualified surgeons, have been demonstrated to be highly 
competent in removing saphenous veins, opening and clos-
ing surgical incisions. acting as first assistant during CABG 
operations and participating in preoperative and postopera-
tive care under the supervision of qualified cardiothoracic 
surgeons. Since the length of the educational process leading 
to qualification as a Surgeon's Assistant in cardiothoracic 
surgery is much shorter than that leading to the MD degree 
and qualification as a cardiothoracic surgeon, and the overall 
responsibilities are less, the compensation of this group of 
health care workers is considerably less than that of qualified 
surgeons. More widespread substitution of surgeons' assis-
tants. in both teaching and nonteaching settings, should 
reduce the costs related to the coronary bypass operation 
without reducing patient benefit and the quality of care. 
4. The postoperative care of the majority of patients 
undergoing routine coronary artery bypass grafting is simple 
and straightforward. Particularly in such patients, unneces-
sary components of care and testing should be avoided. 
5. Complications may increase costs in all these areas, 
and therefore before. during and after the operation tech-
niques and practices that reduce complications without 
endangering comparative benefits should be used. 
X. Patient-Specific Guidelines and 
Indications for the Coronary Artery 
Bypass Operation 
General information on outcome after the coronary artery 
bypass operation is contained in Section III, but it is not 
specific to any given patient because a number of risk factors 
determine the outcome in specific patients. Comparisons 
between outcome after the coronary bypass operation and 
noninterventional medical treatment are presented in Sec-
tion IV. and comparisons between outcome after the coro-
nary bypass operation and coronary angioplasty in Section 
V. These comparisons are group-specific and not specific to 
an individual patient and, although more helpful than simple 
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comparisons in heterogeneous groups of patients, remain of 
limited value. The indications presented in Section VI are 
based on a limited number of risk factors, but they are not 
optimally useful to the physician in working with an individ-
ual patient because patients have a large number of indepen-
dent risk factors, many of which could not be taken into 
account in the general discussion and tables in Section VI. 
This section describes patient-specific predictions and com-
parisons (see Appendix F for methodology) that are opti-
mally useful to the physician in making recommendations to 
individual patients. The technique for generating patient-
specific predictions and comparisons is also optimal for 
exploring the strength of an individual risk factor, for with it 
the values for all other risk factors can be held constant. 
A. Background 
Physicians have traditionally advised patients on the basis 
of the "odds of success" of alternative forms of therapy, and 
the "risks and imponderables" associated with each. In recent 
years sufficient information has been obtained about outcomes 
that the comparative benefits and risks of the coronary bypass 
operation can be computed for an individual patient with his or 
her patient-specific risk factors. 
Many physicians have not had the privilege of using 
computed patient-specific predictions and comparisons as a 
basis for recommendations to patients. Therefore, this sec-
tion provides a limited number of examples, based on the 
equations (mathematical models) currently available for 
these purposes, and describes the potential future availabil-
ity of techniques that simplify for physicians and institutions 
the making of patient-specific predictions and comparisons. 
The information currently available for these purposes is 
limited because of several factors. The medical profession has, 
for the most part, not used its medical expertise to guide 
statisticians in the direction of analyses that would be clinically 
useful. Statisticians have, for the most part, preferred to use 
classical methods, rather than to add to them new methods 
more appropriate to patient care. The major randomized trials 
have generally not encompassed within their reports the types 
of analyses required for predicting and comparing for individ-
ual patients, and most of them have been unwilling even to 
share their data bases with others prepared to make such 
analyses. A notable exception is the United States Department 
of Veterans Affairs, which has shared with this Subcommittee 
certain parts of the data base (that of patients randomly 
assigned to initial medical treatment) from two of their random-
ized trials. The equations derived from these data are useful 
and are included in the report. 
Further development of patient-specific predictions and 
comparisons can ultimately result not only in better, but in 
more economic health care for patients with ischemic heart 
disease. These can indicate, for a specific patient at a given 
time, the comparative benefit and risk of noninterventional 
medical therapy, the coronary bypass operation and coronary 
angioplasty. When sufficient information is available, predic-
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tions and comparisons can also be physician (or surgeon) 
specific and institution specific. The physician, using his judg-
ment and such comparisons and predictions, can provide the 
patient and family with useful and reliable advice. 
The bases of these patient-specific predictions and compar-
isons are multi variable risk factor equations, which generate 
not only the time-related probability of freedom from an 
unfavorable outcome event (and the hazard function for the 
event), but also the confidence intervals around the estimates. 
The confidence intervals quantify the degree of uncertainty in 
the estimate (see discussion of confidence intervals and their 
use in "Task Force Subcommittee Methodology" in Appendix 
C). The patient-specific solutions are most easily used when 
presented as nomograms (plots) of the survivals and hazard 
functions and of the comparative benefits. 
Equations available for generating this information are 
presented in Appendix F. Because the computation of the 
confidence intervals is particularly complex, this is not in-
cluded. The packaging of the multi variable risk factor equa-
tions, and equations for computing confidence intervals, on 
computer software suitable for use in personal computers, is 
the best way of providing physicians and institutions with an 
easy-to-use capability of predicting and comparing for individ-
ual patients and groups of patients. These are available upon 
request from the Task Force Subcommittee. 
B. Example 1 
A 67 year old man without hypertension has moderately 
severe stable angina (Canadian class III), and a history of a 
single previous myocardial infarction. His exercise test is 
strongly positive. He has an 80% proximal stenosis in the left 
anterior descending coronary artery, 30% stenosis in a large 
marginal branch of the circumflex artery and a 20% stenosis in 
the mid-right coronary artery (right dominant system with 
"single vessel disease"). His left ventricular ejection fraction is 
0.55. 
The benefit, with respect to survival, of initial coronary 
bypass surgery (and of initial coronary angioplasty) com-
pared with that of initial medical treatment is illustrated in 
Figure 5. The treatment class of the coronary bypass oper-
ation with respect to survival would be II. 
Example 2 
A 65 year old nonhypertensive man has moderately 
severe stable angina (Canadian class III) and a history of two 
previous myocardial infarctions. His exercise stress test is 
strongly positive. He has three vessel disease with an 80% 
proximal stenosis in his left anterior descending coronary 
artery, 70% stenosis in a large marginal branch of the 
circumflex artery and a 75% stenosis in his mid-right coro-
nary artery (right dominant system). His left ventricular 
ejection fraction is 0.40. 
The comparative benefit with respect to survival, of initial 
coronary bypass surgery (and of initial coronary angioplasty) 
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compared with initial medical treatment is illustrated in 
Figure 6. The treatment class of the coronary bypass oper· 
ation with respect to survival would be 1. 
C. Treatment Class Determined by Patient-
Specific Comparisons 
The patient·specific comparisons are optimal for defining 
the treatment class (Table I) for the coronary bypass oper· 
ation in comparison with medical treatment (or coronary 
angioplasty) in an individual patient. However. defining the 
treatment class is only one step in the process by which the 
physician, using all available information and his or her own 
best jUdgment, determines recommendations to the patient. 
Treatment class I can be considered to apply to situations 
(patients) in which there is I) a computed time-related 
greater probability of freedom from important unfavorable 
events such as death after the coronary bypass operation 
than after initial medical treatment (or after coronary angio-
plasty), and the 70% confidence intervals of the freedom 
after the coronary bypass operation are widely separated 
from those after other treatments. and 2) the 90% confidence 
intervals of the comparative benefit of the coronary bypass 
operation do not touch or overlap zero benefit for that period 
of time. Currently, this prescribed degree of certainty of the 
comparative benefit of the coronary bypass operation can be 
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Figure 5. Nomograms depicting the predicted patient· specific compar· 
ative benefit of the coronary artery bypass operation (CABO), using 
the internal mammary artery to the left anterior descending coronary 
artery (and coronary angioplasty [PTCAl) compared with initial med· 
ical treatment in the 67 year old man with single vessel disease 
(example I). A, predicted percent survival. B, Comparative benefit. 
The confidence intervals in this and D for "CABO minus medical" are 
shaded, and those for "PTCA minus medical" are enclosed by the 
dashed lines. There is only a small comparative benefit of an initial 
coronary bypass operation over initial medical treatment in the 1st 2 
years; this could be due to chance alone. C, Predicted hazard function . 
D. Hazard ratios. For the predictions in this figure and Figure 6. 
equation 2 (Appendix F) was used for initial coronary artery bypass 
surgery, equation 8 was used for initial medical treatment and equation 
12 was used for initial coronary angioplasty. 
reached only when the comparative benefit is considerable. 
When more data from larger groups of patients become 
available, the confidence intervals should become more 
narrow and the prescribed degree of certainty may be 
reached when the comparative benefit of the bypass opera-
tion is small. Then an arbitrary definition may be required as 
to the magnitude of the comparative benefit that would make 
the coronary bypass operation indicated and advisable. 
Treatment class II applies to situations (patients) in which 
there is 1) a computed time-related greater probability of 
freedom after the coronary bypass operation than after 
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Figure 6. Nomograms depicting the predicted patient-specific com· 
parative benefit of the coronary artery bypass (CABG) operation. 
using the internal mammary artery to the left anterior descending 
coronary artery (and of coronary angioplasty [PTCA]) compared 
with initial medical treatment in the 65 year old man with three 
vessel coronary artery disease (example 2). A, Predicted percent 
survival. B, Comparative benefit. There is a considerable compara· 
tive benefit (and no comparative benefit of coronary angioplasty) of 
an initial coronary bypass operation over initial medical treatment , 
and this is very unlikely to be due to chance alone. C, Predicted 
hazard functions. D, Hazard ratios . The hazard ratio for an initial 
coronary artery bypass operation compared with initial medical 
treatment is considerably < I, and the difference from I is very 
unlikely to be due to chance alone. 
medical treatment (or coronary angioplasty), but the 70% 
confidence intervals of the freedom after the bypass opera-
tion touch or overlap for a considerable part of the time with 
those of medical treatment, and 2) the 90% confidence 
intervals of the comparative benefit include (overlap with) 
zero benefit for a considerable period of time. 
Treatment class III applies to situations (patients) in 
which there is no computed time-related comparative benefit 
of the coronary bypass operation over medical treatment. 
(The rationale for these definitions are in "Task Force 
Subcommittee Methodology" in Appendix C). 
Similar treatment classes should soon be definable for the 
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coronary bypass operation in comparison with coronary 
angioplasty or any other form of treatment. 
XI. Bases for Health Care Policy Concerning 
the Coronary Artery Bypass Operation 
Private and public health care policy concerning patients 
with ischemic heart disease should have as part of its bases 
appropriate time-related information concerning unfavorable 
outcome events after alternative forms of treatment. 
Whereas Section X relates primarily to individual patients, 
this section relates primarily to groups of patients. This 
section discusses A) appropriateness of the coronary bypass 
operation, B) quality of care, and C) cumulative years of 
freedom from an unfavorable event. 
Health care policy must of course consider costs as well, 
and this matter has been discussed briefly in Section IX. 
Detailed consideration of cost of the coronary bypass oper-
ation in relation to benefit and health care policy is beyond 
the scope of this report. 
A. Appropriateness of the Coronary 
Bypass Operation 
Widespread inappropriate use of the coronary bypass oper-
ation, or of coronary angioplasty, would be economically 
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wasteful as well as disadvantageous to the individual patient. 
However, the definition of inappropriateness (and, conversely, 
of appropriateness) has not been accomplished with any una-
nimity of opinion, Therefore, many studies of these matters 
have resorted to consensus opinion, derived in one manner or 
another. All such studies are seriously flawed by the biases, 
stated or unstated, of each member of the panel of experts, and 
by the bias underlying the selection of the members of the 
panel. At present, enough information about the coronary 
artery bypass operation exists, as summarized in this report, 
that the seeking of consensus opinion is no longer necessary. 
Appropriateness of a procedure is generally sought retro-
spectively. In this regard, it is similar to quality of care, 
discussed in the next part of this section. Appropriateness of a 
procedure, such as the coronary bypass operation, should be 
assessed on the basis of the time-related results of the proce-
dure. Appropriateness is analogous to the indications for the 
operation, except that the indications are sought prospectively, 
before the procedure. Thus the methodology for determining 
the patient-specific indications for a procedure (see Section Xl 
also applies to determining appropriateness. 
An interventional procedure can be considered to have 
been appropriate (as compared with medical treatment) for 
an individual patient when its treatment class is I (as defined 
by patient-specific criteria in part C of Section Xl. The 
appropriateness of a procedure that, for an individual pa-
tient, is in treatment class II is uncertain, and it should be 
decided administratively. Comparative costs should proba-
bly be considered. New procedures will often fall into 
treatment class II, because of the small numbers of patients 
for analysis with resultant wide confidence intervals and the 
relatively short period of follow-up. Therefore, new and 
promising procedures in treatment class II may be consid-
ered appropriate for a few years. A procedure can be 
considered inappropriate when its treatment class is III. 
The same procedure can be used to evaluate the appro-
priateness of one type of interventional procedure (such as 
coronary angiopiasty) in comparison with that of another 
(such as the coronary bypass operation). 
B. Quality of Care 
Quality of care in the case of the coronary bypass operation 
is currently judged on the basis of hospital mortality. An 
assessment of quality of care on this basis has been done in an 
exemplary manner by the Department of Health of the state of 
New York. There, Hannan and colleagues (116,117) have 
developed a reporting system from each of the 30 hospitals in 
the state performing cardiac surgery, and that system has 
provided data for multivariable analysis and identification of 
the incremental risk factors for hospital death in their popula-
tion of patients. With use of the derived risk factor equation, an 
expected hospital mortality with its 95% confidence intervals 
was computed for each hospital in the state. The expected 
hospital mortality was defined as the mortality to be expected 
had that hospital's specific patients, with their patient-specific 
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risk factors, been operated on, so to speak, by the state of New 
York as a whole. Hospitals whose actual mortality rate was 
above the 95% confidence intervals of the expected mortality 
rate could be considered to be failing to deliver care of good 
quality. With further refinements, these techniques were used 
to rank the hospitals in the state according to quality of care as 
judged by risk-adjusted hospital mortality. 
Ideally, morbidity and length of hospital stay, as well as 
mortality, should be computed and compared in a similar 
risk-adjusted manner, and considered in an overall evalua-
tion of quality of care in the case of the coronary bypass 
operation. The physical and emotional comfort of the pa-
tients and family also require consideration in this regard. 
In the quest for a low hospital mortality rate, it must always 
be remembered that the coronary bypass operation may, in the 
best of hands, currently have a relatively high hospital mortal-
ity in certain types of cases, and still have for these cases a 
larger and near-certain comparative benefit (appropriateness) 
when compared with alternative forms of treatment. 
C. Cumulative Years of Freedom From an 
Unfavorable Event 
Most physicians and patients think in terms of and use the 
time-related probability of freedom from alternative forms of 
therapy. Life insurance actuaries and government often use 
the cumulative years of freedom from an unfavorable event, 
also termed the percent retention of potential time of free-
dom from an unfavorable event. This latter criterion is 
appropriate when the goal is preservation of total years of 
life of a skilled work force, or the calculation of costs in 
terms of preservation of the maximal number of years of life, 
or consideration of the resources necessary to pay pensions 
and annuities of a given population. The important point is 
that a different answer is obtained, depending on the criteria 
used, and failure to understand this could create confusion 
and lead to unnecessary conflict. 
An example is presented in Figures 7 and 8. In Figure 7, 
the information is depicted in the form used throughout this 
ACC/AHA Task Force Subcommittee Report, with the 
time-related probability of survival after coronary bypass 
and after initial medical treatment depicted on the left side 
and the hazard function on the right. With use of the derived 
equations, the probabilities have been extended to 16 years, 
in order to see clearly the time when they cross. The 
"crossing point" is at a different interval after starting 
treatment in the survival plot (10.7 years), compared with 
the hazard function (6.6 years). 
In Figure 8, the same information is presented in terms of 
the percent retention of potential lifetime (freedom from 
death) (\26-128). In this criterion, the survival curves after 
the coronary bypass operation and that after initial medical 
treatment cross twice, and the last crossing is at 16.1 years. 
These three different times, at which the curves come 
together and then cross, result from three different criteria, 
or methods of presenting the information. 
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Figure 7 (above). Percent survival and hazard function for death, 
and the comparative benefits in these regards, of randomly assigned 
coronary bypass surgery compared with randomly assigned initial 
medical treatment (28). A, Survival. Note the two survival curves 
come together 10.7 years after the start of therapy. B, Comparative 
surgical benefit of the coronary bypass operation (surgical benefit). 
The comparative benefit becomes zero 10.7 years after beginning 
therapy. C, Hazard functions. They become the same 6.6 years after 
the start of the treatment strategies. D, Comparative hazard ratio. 
The ratio becomes I (instantaneous risk of death becomes the same 
for both treatment strategies) at 6.6 years. 
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Appendix A 
The Coronary Artery Bypass Graft Operation (Section II) 
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Figure Al (above). Patency of internal mammary artery and saphe-
nous vein grafts at 1 year intervals after insertion. Reproduced. with 
permission, from Loop et al. (4). 
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Figure A2 (below). Illustration of the advantage, in terms of pre-
dicted survival (A). and hazard function (B), of the use of the 
internal mammary artery (lMA) in the coronary artery bypass 
operation in an elderly patient in the current era. The advantage of 
use of the internal mammary artery is not apparent until about the 
4th postoperative year. Data based on nomogram of a specific 
solution of a multivariable risk factor equation for death (5.6). 
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Appendix B 
Status After the Coronary Bypass Operation (Outcome Events) 
(Section III) 
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Figure 81. Relation between the number of 
importantly stenosed vessels and the compar-
ative benefit of surgery (the coronary artery 
bypass operation compared with initial medi-
cal treatment) in terms of risk factor-adjusted 
freedom from cardiovascular death. Repro-
duced with permission from Califf et al. (35). 
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Figure 82. Relation between left ventricular dysfunction 
(ejection fraction) and the comparative benefit of surgery 
(the coronary artery bypass operation compared with 
initial medical treatment), in terms of risk factor-adjusted 
freedom from cardiovascular death. Reproduced with 
permission from Califf et al. (35). 
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Figure B3. Hazard function for postbypass return of 
angina in a heterogeneous group of patients (5,6). 
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Figure B4. Comparative benefit of the use of the internal mammary 
artery (lMA) versus use of vein grafts only, in terms of freedom 
from angina. A, Nomogram of the risk-adjusted time-related prob-
ability of freedom from angina after the coronary artery bypass 
(CABO) operation, according to whether the internal mammary 
artery was or was not used (a specific solution of the KUL 
multivariable equation for freedom from return of angina [5]). The 
nomogram has two curves, but they are virtually the same. B, 
Comparative benefit of use of the internal mammary artery. The 
slight discrepancy of B compared with A is due to the greatly 
expanded vertical axis in B. 
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Appendix C 
Comparisons of the Coronary Bypass Operation With Medical 
Therapy (Section IV) 
Task Force Subcommittee Methodology 
Publications concerned with time-related freedom from unfavorable 
events in patients with ischemic heart disease have used a wide 
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*The prevalences in the subset with a positive graded exercise test. and in 
that with a markedly positive graded exercise test. are not available. LM = 
left main. 
JACC Vol. 17, No.3 
March 1, 1991 :543-89 
variety of methods of analysis and techniques of reporting and 
displaying information. They have also varied widely in the amount 
of detail included about the prevalence of the potential risk factors 
in the groups and subgroups described. A similar variety of methods 
have been used to compare results of one method of treatment with 
those of another. This has made troublesome the obtaining of a 
complete overview of the results of the coronary artery bypass 
operation compared with those of medical treatment (or coronary 
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Figure C1. Comparison of survival after randomly assigned surgery 
(CABG operation) with that after randomly assigned initial medical 
treatment, according to the results of graded exercise testing (GXT) 
(25). (See prevalences of risk factors in the accompanying Table EJ. 
A, Survival in patients with a positive graded exercise test. B, 
Comparative benefit. in terms of survival. of an initial coronary 
bypass operation versus initial medical treatment in patients with a 
positive graded exercise test. C. Format as in A, but in patients with 
a //larkedlv positil'c graded exercise test. D. Format similar to B, but 
in patients with a //lllrkedly positil'e graded exercise test. Note that 
the surgical benefit is greater in this group. 
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Figure C2. Comparison of survival after randomly assigned surgery 
(coronary artery bypass operation) with that after randomly as-
signed initial medical treatment. in patients with III/stahle (/Ilgil/(/ 
(31), (See prevalences of risk factors in accompanying Table E), A. 
Survival of the overall group, B. Comparative benefit. in terms of 
survival. The inclusion of the zero horizontal line by the 90'/( 
confidence intervals indicates that the small comparative advantage 
of surgery could be due to chance alone, C. Format as in A. but in 
patients with unstable angina and three vessel coronary artery 
disease, D. Format as in B. but in patients with unstable angina and 
three vessel coronary artery disease, The relation of the 9()r;~ 
confidence intervals to the zero horizontal line indicates that the 
surgical benefit after 2 years is unlikely to be due to chance alone, 
angioplasty). and has led to the impression that there is inconsis-
tency among reports, This impression is not supported by the 
findings of this Subcommittee, 
For use by the Subcommittee. the data and information in each 
of the major publications have been reorganized into a common 
format. (The Subcommittee expresses its appreciation to Dr. David 
Naftel for performing these computations and reorganizations,) 
Information about the prevalence of potential risk fadar, in the 
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o Years P1-F5C 
Prevalences of Risk Factors in the Veterans Affairs 
E Randomized Trial of Unstable Angina (31 ) 
Overall Group 
---------
Characteristic" Surgical Medical 
-.--------------~ ---- " 
~umher of ratienh In) 231 237 
Age I\r) 50 :+: 7, I 50 :! o,~ 
Slenosed vessels 
I vessel l'i'; 1\1'; 
2 \e\\eJ\ 1,7' ; 1,3'; 
" \'(ssels 441; 4X', 
Ahnormal LV 2~( ; 291 (-
functioll 
Ejection fraction (1,64 :! (),14 (I,o} :! 0,13 
Diahetes 16(, I~S; 
SmOKing 46(; 451 ; 
Era 1~76-I')X2 1l}7h-I~X2 
RCI'ascularilation 2,7 grans 
\1ean value. or I, of n, LV = len ventricular. 
Patients With} 
Ves,e\ Di~ease 
Surgical Medical 
102 114 
O~i WI, 
()f/f WX 
IO(lS'; IOW/f 
patient ,ubgroups presented has been juxtaposed with the graphIC 
presentations of outcome to facilitate interpretation. Only a fraction 
of the reformatted analyses are presented in this report. 
The concept of comparative benefit. This concept. introduced by 
Califr and colleagues (35). was adopted as a proper method for 
making comparisons, Four depictions were used to present the 
comparative benefit in terms of freedom from a specific unfavorable 
event I see. for example. Appendix D. Fig, 01), In the upper left was 
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E 
Prevalences of Risk Factors in Two Groups of Patients With 
Left Main Coronary Artery Disease (29,81) 
Characteristic* 
Number of patients (n) 
Age (years) 
Stenosed vessels 
I vessel 
2 vessels 
3 vessels 
LM >75% 
Ejection fraction >0.50 
Diabetes 
Hypertension 
Smoking 
Era 
Revascularization 
V A Randomized Trial 
Surgical 
48 
81% 
48% 
17% 
27% 
Medical 
43 
93% 
49% 
28% 
30% 
1972-1974 
2.3 grafts 
CASS Registry 
Surgical Medical 
1111 281 
57 ± 9t 
13%t 
27%t 
53%t 
57 ± 0.16t 
13%t 
37%t 
76%t 
1975-1979 
*Mean value, or % of n. tThese data are for the overall group. undiffer· 
entiated as to surgical versus medical treatment. CASS = Coronary Artery 
Surgery Study; LM = left main coronary artery; VA = Veterans Affairs. 
depicted the time·related probability offreedom from the event after 
the coronary artery bypass operation, for example, and that after an 
alternative form of treatment, such as initial medical treatment (or 
coronary angioplasty). In the lower left was presented the compar-
ative benefit, or the time-related difference in the probability of 
freedom after the two therapies, "+" resulting from a greater 
freedom after the coronary bypass operation and indicating a 
comparative benefit in favor of the operation and "-" resulting 
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~«l 
:. 
20 
10 
c 
Years 
Survival ("'I ----------
Surgical 
Medical 
1/12 
115'" 
III'" 
II"'" 
87'" 
Left Main Disease 
(ASS Registry (1989) 
2 
Years 
3 
JACC Vol. 17. No.3 
March 1. 1991 :543-89 
4 5 
T3-FIB 
Surgical «l ~-----------------­
Benefit 
o 0 
20 
10 
Difference 
inPercent 0 bJj::&.:..=....-----------------
Survival 
-10 
-20 
o 
Years 
Difference ("'I 
1/12 
Surgical. Medical -1.0'" 7.2'" 28'" 
2 :s 
Years 
4 5 
n-F •• 
Figure C3. Comparison of survival after surgery (coronary artery 
bypass operation) with that after initial medical treatment in patients 
with left main coronary artery disease. See prevalences of risk 
factors in accompanying table E. A, Survival after randomly as-
signed treatment (29). B, Comparative benefit, in terms of survival. 
The surgical advantage is appreciable, and the position of the 90% 
confidence intervals relative to the zero line indicates that it is 
unlikely to be due to chance alone. C, Format similar to A but 
showing data for symptomatic patients with nonrandomly assigned 
treatment (81). D, Format similar to B but showing data for 
symptomatic patients with nonrandomly assigned treatment (81). 
Note the similarity to B. 
from a lesser freedom after the operation and indicating a compar-
ative benefit in favor of the alternative form of treatment. In the 
upper right was presented time-related hazard functions for the 
unfavorable outcome event after the two forms of therapy. In the 
lower right was presented the time-related hazard ratio, depicting 
again the benefit from the operation or lack thereof. Here no 
difference was indicated by "1," a benefit from the operation by a 
ratio < I, and benefit from the alternative form of therapy by a ratio 
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2.0 3-Vessel Disease 
1 Proximal Stenosis 
10 CASS Registry (1989) 
94% 
87% 
> I. (in many figures in the report. such as Figure C'+. the hazard 
functions and hazard ratio were not included hecause of limitation;, 
of space.) 
Typically. in the two upper depiction;, the 7W; confidence 
intervals around the continuous point estimates of freedom after 
each of the two treatment strategies were shown. 70(; confidence 
intervals (rather than the wider 95(; confidence intervab) were used 
because of the unreasonahleness in clinical medicine of concluding 
"I/O benefit" primarily hecause of a fairly small numher of patient-, 
in a study. This could happen were the criteria to be nonoverlapping 
9Y7c confidence intervals (or a p value <0.051. In the two lo\\cr 
depictions, the "0" and" I" had no confidence intemtls. ,0 the 
lines of comparative benefit were surrounded bv their 90'; confi-
dence intervals. 
When the 70'1( confidence intervals of the time-related probabil-
ities of freedom for each of the two treatments were widely 
separated, a p value :s0.05 was assured, and the inference was that 
a "near certain difference" existed. When the 70(; intervals nearly 
but not quite touched, a p value :sO.IO was likely. and the inference 
was that a "probable difference" existed. These two situations have 
been classified as treatment class I (Table II. When the 70(; 
confidence intervals touched or overlapped, the inference was that 
"any difference could be due to chance alone." This situation has 
been classified as treatment class II. 
When the 90'1( confidence interval of the time-related ditji'/'('lIcc 
between the probabilities of freedom of the two treatments was 
widely separated from 0, a p value :sO.05 was assured. and the 
inference was that a "near certain benefit" existed. When the 90'( 
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Figure C~. Comparison of survival after nonrandomly assigned 
surgery (coronary artery bypass operation) with that after initial 
medical treatment. in patients with three vessel disease, according 
to the number of proximal stenoses (33). See prevalences of risk 
factor, in Figure 3E (table) under "Angina III-IV." A, Survival in 
patienh with no proximal stenosis. B. Format similar to A, except 
that one proximal 'itenosis was present. C. Format similar to A, 
except that two proximal stenoses were present. D, Format similar 
to A except that three proximal stenoses were present. Note the 
graduallv decreasing survival with initial medical treatment in these 
four graphs. and the consequent progressive increase in surgical 
henefit. Survival after coronary bypass surgery is similar in the four 
group,. indicating that the bypass operation has neutralized the 
incremental ri,k of the proximal stenoses. 
interval nearly hut not quite touched zero, a p value :s0.10 was 
assured. and the inference was that a "probable benefit" existed. 
These situations again have been classified as treatment class I. 
When the 90r;( confidence interval touched or overlapped zero, the 
inference was that "any benefit could be due to chance alone." This 
situation has been classified as treatment class II. When the depic-
tion of the two separate probabilities of freedom and the compara-
tive benefit indicated that there was no advantage of the coronary 
artery bypass operation. the treatment class was considered to be 
III. 
Generating a hazard function equation. The process of converting 
the depictions in a publication into the Subcommittee format con-
,isted of generating an equation in the hazard function domain, from 
578 KIRKLIN ET AL. 
ACC/AHA TASK FORCE REPORT 
l00r~---~---_ ~ 80 ........ ~~::-----v~:-:_
eo Years 
70 .. 
.~ eo 
'" ~S) 
c:: .. 
~«I .. 
A-
S) 
2ID 
10 
Survival(%) ---------
1/12 5 10 
Surgical 97% 96% 92% 80% 
Medical 99.3% 98% 91% 83% 
No Proximal LAD Stenosis 
European Randomized Trial (1988) 
°0~~~~2~~~~~4L-~5L-~eL-~T~~e~~8~~'0 
A 
Y.ars Vl-F5A 
Surgical 2ID r--------------------
Benefit 
15 
10 
.. ----_ ... -------- ............ .. . -.. -.... ---5 _..... 0 
Difference t -:-=--.:.:.:.;;·~·::.-======JoC=:::::::.:;:-.~--in Percent 0 to 0 
Survival o --- .............. 
Difference(%) --------- •••• 
.............. 
Years 
1/12 5 10 -10 
Surgical-Medical -2.5% -1.8% -1.7% -3.1% 
-15 
Medical 
Benefit ...., 0~~L-~2~~~~~4 ...... ~5~~e~~T ........ ......L ........ ......L8 ........ ...J,0 
8 
Y .... 
Y1-F5A 
Figure CS. Comparison of survival according to the presence or 
absence of a proximal left anterior descending coronary artery 
stenosis in patients with multivessel disease. See prevalences of risk 
factors in the table accompanying Figure C I. A, Survival after 
randomly assigned initial surgery (coronary artery bypass operation) 
in such patients without a proximal stenosis in the left anterior 
descending coronary artery, compared with that after initial medical 
treatment (25). B, Comparative benefit, in terms of survival, of the 
coronary bypass operation versus initial medical treatment in the 
same group of patients. The graph indicates that the small surgical 
benefit could be due to chance alone. C, Format similar to A, but 
based on such patients with an important proximal stenosis in the 
left anterior descending coronary artery (25). The decreased sur-
vival with initial medical treatment, compared with that in patients 
without a proximal stenosis. D, Comparative benefit in the same 
group of patients. The graph indicates that the considerable surgical 
benefit is unlikely to be due to chance alone. 
which the continuous point estimate and confidence intervals of 
both the probability of freedom and the hazard function could be 
generated (24). This was begun by converting the usual life-table 
depiction of the publication into the cumulative hazard function 
domain. (When an original data set is being analyzed parametrically, 
the first informal estimate of the number of hazard phases is made in 
this domain.) A three phase hazard function was initially assumed to 
100 
90 
80 
70 Survival (%) --------
.. 1/12 S ·s 60 :; Surgical 97% 96% 92% 
~ 50 Medical 96% 93% 83% 
c:: 
~«l 
Gi 
A-
20 
Proximal LAD Stenosis 
10 European Randomized Trial (1988) 
2 
c 
5 
Years 
6 
JACC Vol. 17, No.3 
March I, 1991:543-89 
7 8 9 10 
V1-F58 
Surgical 20 ......--------------------
Benefit 
15 ---
10 
5 
Difference 
in Percent 0 ~.:..:...-----------------­
Survival Years 
-s Difference (%) 
1/12 S 10 
-10 Surgical-Medical 1.1% 3.1% 9.7% 10% 
-15 
Medical 
Benefit -20 L-.........J~.........J~---'~......L ........ ~~.....L.~ ....... ~__'_~_'_............J 
o 2' 4 5 15 7 8 " 10 
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Y.... Vl-FI8 
be present (a reasonable assumption from many previous analyses 
of alternative forms of treatment, including medical treatment, for 
ischemic heart disease). Then the data were tested for their fit to this 
assumption. If indicated by this fitting, one or more phases were 
deleted. Then the data were expressed in an equation, using the 
techniques of the parametric method in the hazard function domain 
(24). In the Subcommittee depictions, the actuarial estimates from 
the paper were also depicted, to provide a validation of the para-
metric estimate. 
The confidence intervals from the usual variance-covariance 
matrix in the parametric method are mainly dependent on the total 
number of events occurring during the period of study. The raw data 
necessary for the computation of the variance-covariance matrix 
were not in the publications from the literature. However, the total 
number of events was usually stated or could be calculated. The 
confidence intervals were therefore estimated using this number, 
recognizing that this was only the best possible estimate under the 
circumstances. 
This method has been validated by comparing the Subcommittee 
depiction of the time-related probability of survival, with its confi-
dence intervals, after randomly assigned initial medical treatment in 
the Veterans Administration trial (as seen in Fig. 7) with those 
obtained by a parametric analysis of the original data. The corre-
spondence was very close. (These data may be obtained from the 
Subcommittee on request.) 
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Figure C6. Comparison of survival after nonrandomly assigned 
surgery (coronary artery bypass operation) with that after initial 
medical treatment, in patients with three vessel disease and severe 
angina, according to the severity of left ventricular dysfunction (33). 
See prevalences of risk factors in Figure 3E (table) under "Angina 
III-IV."). A, Survival in patients with mild left ventricular dysfunc-
tion. B, Comparative benefit. The graph indicates that the important 
surgical benefit is unlikely to be due to chance alone. C, Format 
similar to A, but showing data for patients with severe left ventric-
ular dysfunction. Note that the surgical survival at 1 month and 5 
years is less than that when left ventricular dysfunction is mild. D, 
Format similar to B but showing data for patients with severe left 
ventricular dysfunction. The data emphasize that the surgical benefit 
is greater when left ventricular dysfunction is severe than when it is 
mild, even though the 1 month and 5 year surgical survival rates are 
lower than when dysfunction is mild. 
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Appendix D 
Comparison of the Coronary Artery Bypass Operation With 
Coronary Angioplasty (Section V) 
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Coronary Artery Bypass Operation (CABG) or Angioplasty 
(PTCA) 
Characteristic CABG PTCA 
Number of patients (n) 1000 389 
Age Iyr) 59 55 
Stenosed vessles 
I vessel 49t 607r 
2 vessels ~27r m{ 
3 vessels 759t 67r 
Left main stenosis 219t 17r 
Prior myocardial infarction 539t Wir 
Ejection fraction 0.59 n.65 
Unstable Angina 209t 40r;i 
*Data for both groups are for 1981 to 1986 (70). Note the increased 
prevalence of most risk factors in the patients undergoing the coronary bypass 
operation. 
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Figure D1. Comparison of survival after nonrandomly assigned 
initial coronary artery bypass surgery with that after initial coronary 
angioplasty in heterogeneous groups of patients (70). See preva-
lences of risk factors in accompanying Table E. A. Survival (without 
risk adjustment). B. Comparative benefits. There appears to be a 
small benefit of angioplasty. but this was not confirmed by multi-
variable Cox regression analysis for risk factor adjustment. C. 
Hazard functions (each with two phases) for death. The constant 
phase of hazard is higher after the coronary bypass operation 
(surgical treatment). D. The hazard ratio. This indicates that in the 
heterogeneous groups the improved comparative benefit of coronary 
angioplasty is unlikely to be due to chance alone. but Cox multi-
variable regression analysis did not confirm this. 
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Figure D2. Comparison of predicted survival and hazard functions 
after the coronary artery bypass operation with that after coronary 
angioplasty in elderly patients (>70 years of age) with three vessel 
coronary artery disease and mild left ventricular dysfunction. Both 
depictions are nomograms of patient-specific (risk factor-adjusted) 
solutions of multi variable risk factor equations (6,73). A. Survival. 
B, Comparative benefit. The comparative benefit of the coronary 
bypass operation is unlikely to be due to chance alone. C, Hazard 
function. D, Hazard ratio, showing a comparative benefit of the 
coronary bypass operation that is unlikely to be due to chance alone. 
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Appendix E 
Indications for the Coronary Bypass Operation (Section VI) 
Definitions 
A. Sel'erity of Angina (Canadian ClIrdio\'{/Scular Society) (129) 
Class / angina occurs only with strenuous or prolonged exertion 
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Figure D3. Comparison of freedom from angina after nonrandomly 
assigned coronary bypass surgery with that after coronary angio· 
plasty (69). (See prevalences of risk factors in accompanying Table 
E). A, Freedom from return of angina. Although the treatments were 
nonrandomly assigned, the method of the study assured that all 
patients were suitable for both treatments, and resulted in well· 
matched populations. B, Comparative benefit. The comparative 
benefit in terms of the coronary bypass operation is unlikely to be 
due to chance alone. C. Hazard functions for return of angina. D, 
Hazard ratio. The benefit of the coronary bypass operation is 
unlikely to be due to chance alone. 
at work or recreation and does not occur with ordinary physical 
activity. 
CI{lss II {lngin{l occurs with walking rapidly on level ground or a 
grade and with rapidly walking up stairs. Ordinary walking for <2 
blocks on the level or climbing one flight of stairs does not cause 
angina except during the first few hours after awakening, after 
meals. under emotional stress. in the wind or in cold weather. This 
implies slight limitation of ordinary activity. 
CI{lSS /1/ {lngina occurs when walking <2 blocks on level ground 
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at a normal pace, under normal conditions, or when climbing one 
flight of stairs. This implies marked limitation of ordinary physical 
activity. 
Class IV (Il/gilla occurs with even mild activity, and may occur 
at rest but must be of brief «15 min) duration. (If the angina i~ of 
longer duration, it is called unstable angina.) This implies inability to 
carry out even mild physical activity. 
B. Unstable Angina 
Unstable angina has been variously defined by practitioners (130) 
by the randomized trials of unstable angina (30,3 1.131) and more 
recently in a summarizing paper by Braunwald (132). For the 
purposes of this report. establishing subgroups of unstable angina 
seemed unwise. since no clear relation of subgroups to outcome has 
been established. In any event. unstable angina is taken as clear 
evidence of important reversible myocardial ischemia. 
In this report. ullstable allgilla implies one of several syndromes. 
It applies to patients with severe and persisting angina on presenta-
tion to the physician or hospital. with electrocardiographic (ECG) 
evidence of ischemia and only minor creatine kinase. MB isoenzyme 
evidence (available only later) of myocardial infarction. The syn-
drome is considered more ominous if it occurs in the absence of 
stimuli to increased total body oxygen consumption or catechol-
amine release (unusual emotional stress, fever. infection. hypoten-
sion or uncontrolled hypertension. tachyarrhythmia or hypoxemia). 
It also applies to patients who have new onset angina (Canadian 
class IV) within 2 months of presentation, or recurring or prolonged 
(> 15 min) severe angina within 10 days of presentation, whether or 
not it is new. The phrase is also appropriate to patienh who develop 
(or continue with) severe angina within 2 week, of an acute 
myocardial infarction. In all subsets. there will usually he ECG 
evidence of myocardial ischemia during the severe pain, and no 
evidence of more than minimal myocardial necrosis. 
C. Moderate or Se\'ere Mrocardial Ischcmia With NOllil/l'iI.lil'c 
Stress Testing 
This report uses only two categorizations of the results of 
noninvasive stress testing: I) no or mild myocardial ischemia. and 2) 
moderate or severe myocardial ischemia (positive results). For the 
purposes of this report. evidence of moderate or severe myocardial 
ischemia in patients with coronary artery disease includes 
I. On exercise electrographic testing with a low level of exercise 
(sstage 2 Bruce protocol. or s6.5 metabolic equivalents IMET) 
(approximately 3.5 ml oxygen uptake·kg·min- 1 ). or maximal work 
load <100 WI: a) 2:1 mm ischemic (horizontal or downsloping) ST 
segment depression in mUltiple leads: b) ECG changes lasting 
>6 min after cessation of exercise: c) sustained decrea,e > 10 mm 
Hg in systolic blood pressure. or a lower than usual systolic hlood 
pressure (s130 mm Hg) in response to the exercise: dl ventricular 
tachycardia: e) angina. 
2. On thallium scintigraphy: a) reversible thallium defects in 
more than one area at risk, or in a very large single area: hi increased 
thallium uptake by the lungs during exercise (reflecting pulmonary 
edema). 
3. On radionuclide testing: a) exercise-induced reduction in 
ejection fraction 2:0.10: b) development of segmental wall motion 
abnormalities: c) exercise-induced left ventricular cavity dilation. 
This general area has been well reviewed in three previous Task 
Force reports (101.133.134). 
D. Distributioll alld SCl'crity of Corollary Artcn' LJi.H'(/se 
A stenosis is, for the purposes of this report. considered impor-
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tant in the coronary arteries when it produces 2:70% reduction in the 
luminal diameter of the vessel. (However. some multivariable risk 
factor analyses have found stenoses 2:50% to be risk factors for an 
unfavorable outcome event.) An exception is the left main coronary 
artery. in which a 2:)09( reduction in luminal diameter is considered 
to be an important stenosis. 
The phrases one vessel. two vessel. or three vessel coronary 
artery disease consider as "a vessel" the left anterior descending 
coronary artery. the right coronary artery or the posterior descend-
ing coronary artery. and the left circumflex coronary artery and/or 
one or more large marginal branches. The circulation should always 
be labeled "right dominant," "left dominant." or "co-dominant." 
according to the origin of the posterior descending coronary artery. 
E. Left VClltricular LJl'sfill1ctioll 
For the purposes of this report. left ventricular dysfunction at 
rest has heen termed "absent. grade 0." or "present. and mild. 
moderate or severe in degree" on the basis of ejection fraction or 
Coronary Artery Surgery Study (CASS) score (Table Ell. or an 
interpretation of the functional significance of other quantitative 
measurements of left ventricular function. such as radionuclide 
techniques. In some multi variable analyses. other arbitrary criteria 
have been used. including four grades of left ventricular dysfunc-
tion. In one randomized trial. a simple yes or no indication of the 
presence of dysfunction was used. 
Table EI. Interrelations Between "Left Ventricular Dysfunction" at 
Rest. Ejection Fraction and Coronary Artery Surgery Study (CASS) 
Score 
Left Ventriclilar Ejection Fraction C ASS Score i26,RO) 
Dy,fllnction < :5 < --- s 
0 0.60 15 is normal I 
Mild 0.50 0.60 5 9 
Moderate OJ~ 0.50 9 --- 15 
Severe OJ5 15 
'These interrelations are for the purposes of this report. and are some-
what arbitrary. although in general agreement with the interrelations de-
scribed in other reporh. 
Appendix F 
Patient-Specific Guidelines and Indications for the Coronary 
Bypass Operation (Section X) 
MetllOdo{VRY 
The methodology for patient-specific predicting and comparing is 
simple. and in essence has been described in Section X and alluded 
to in other parts of the report. The bases of the methodology are 
multi variable risk factor equations, preferably in the hazard function 
domain. 
The equations currently available for patient-specific predicting 
and comparing. along with coefficients and p values. are depicted on 
the following pages. The confidence intervals are determined by the 
variance-covariance matrix. which is more complex than can con-
venientl\" be printed. The equations and the variance-covariance 
matrix (for confidence intervals) are available as computer software 
from the Subcommittee. These can be used in a personal computer 
for generating patient-specific predictions and comparisons. 
The Subcommittee deeply appreciates the privilege of using the 
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multi variable risk factor equations in the hazard function domain for 
probability of freedom from unfavorable outcome events after the 
coronary bypass operation, derived in collaboration with and from 
the data base of Dr. Paul Sergeant and his colleagues in cardiac 
surgery at the Katholieke Universiteit in Leuven, Belgium (KUL) 
(5) (Sergeant PI. Blackstone EH, Lesaffre E, Flameng W, Kirklin 
JW. Unpublished study, 1990). The Subcommittee also expresses its 
deep appreciation to Drs. Timothy Takaro, Herbert Hultgren, Peter 
Peduzzi, Katherine Detre and the Department of Veterans Affairs 
for providing the data base of patients with stable angina random-
ized to initial medical treatment in the Veterans Affairs randomized 
trial (28,29). The Subcommittee is also deeply grateful for the very 
helpful collaboration of Drs. Stewart Scott, Robert Luchi and RH 
Deupree, and the Department of Veterans Affairs in providing the 
data base of patients with unstable angina randomized to initial 
medical treatment in the Veterans Affairs trial (30.31). These data 
bases were subjected to multivariable risk factor analysis in the 
hazard function domain by Dr. EH Blackstone, for the Subcommit-
tee. The other equations have been previously published. 
Confidence intervals when predicting for an individual 
There is a tendency to believe that the confidence intervals are 
wider when predicting time-related probability of freedom from an 
unfavorable outcome event for an individual, than when predicting 
it for a group. To some extent this is based on a misunderstanding of 
what is being predicted, and to some extent it reflects the fact that 
this matter remains one of opinion and not one of proof. It is the 
opinion of the Subcommittee, on the basis of expert statistical 
advice, that the width of the confidence intervals when predicting 
time-related probability (a parameter estimate) for an individual is 
the same as when predicting for a group. (The details of the logic and 
statistical and mathematical bases for this belief are available from 
the Subcommittee on request.) 
The Equations 
The form of the risk factor equations is the log-linear one (24). 
The definitions and units of variables appearing more than once in a 
set of equations are in all instances the same as in their initial use. 
L MuItivariable risk factor equation for death after the coronary 
bypass operation (UAB, 1977-1981). This equation is given in the 
original publication (34). 
2. MuItivariable risk factor equation for death after the coronary 
bypass operation (KUL). For the three hazard phases, shaping 
parameter estimates and incremental risk factors, their coefficients, 
standard deviations and p values were: 
Early: 8 = 0, p = 0.1113, v = 1.443, m = 0, intercept = -5.901, 
age (years) = 0.05760 ± 0.0138 (p < 0.0001), left main disease (0 = 
no, :::::90% stenosis = I) 0.6730 ± 0.31 (p = 0.03), ejection fraction 
= -2.082 ± 0.77 (p = 0.007), left ventricular hypertrophy (0 = no, 
I = yes) = 0.8049 ± 0.29 (p = 0.006), severity of angina (0 = none, 
I = mild stable angina, 2 = moderate or severe stable angina, 3 = 
severe nonexertional angina, 4 = unstable angina) = 0.6126 ± 0.111 
(p < 0.0001), hemodynamic instability (0 = none, I = instability 
without shock, 4 = cardiogenic shock) = 0.4533 ± 0.125 (p = 
0.0003), peripheral vascular disease (0 = no, I = yes) = 0.6345 ± 
0.22 (p = 0.004), small coronary arteries (ratio of number of I mm 
or smaller distal coronary anastomoses to number of distal anasto-
moses) = 1.396 ± 0.43 (p = 0.001), insulin-treated diabetes (0 = no, 
I = yes) = 0.8807 ± 0.35 (p = 0.01), I-second expiratory rate (% of 
normal) = -0.02125 ± 0.0056 (p = 0.0001). date of operation (years 
since II7l) = -0.08312 ± 0.032 (p = 0.01), surgeon B (0 = no, I = 
yes) = 0.5546 ± 0.22 (p = 0.01), number of endarterectomies = 
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0.6609 ± 0.24 (p = 0.007), sequential grafting (ratio of number of 
distal anastomoses to number of conduits) = 0.3538 ± 0.122 (p = 
0.004). 
Constant: intercept = -4.709, ejection fraction = -3.806 ± 0.77 
(p < 0.0001). ischemic mitral incompetence (0 = no, I = yes) = 
0.7834 ± 0.26 (p = 0.002), no anginal symptoms (0 = no, I = yes) 
= 0.6196 ± 0.23 (p = 0.007), unstable angina (0 = no, 1 = yes) = 
0.7944 ± 0.20 (p < 0.0001), peripheral vascular disease = 0.6226 ± 
0.23 (p = 0.007), high density lipoprotein level (mg·dl- 1) = -0.01820 
± 0.0092 (p = 0.05), incomplete revascularization (0 = no, 1 = 
:::::70% stenosis remaining unbypassed) = 0.8025 ± 0.190 (p < 
0.0001). 
Late (rising): 1 = 1, 'Y = La = L 1/ = 3.526, intercept = 9.827, 
age = 0.2620 ± 0.080 (p = 0.001), age (natural logarithm transfor-
mation) = -11.18 ± 4.1 (p = 0.006), number of diseased vessels (l 
to 3, :::::70% stenosis) = 0.3219 ± 0.140 (p = 0.02), ejection fraction 
= -2.287 ± 1.10 (p = 0.04), peripheral vascular disease = 0.6530 ± 
0.23 (p = 0.005), small coronary arteries = 1.229 ± 0.40 (p = 0.002), 
insulin-treated diabetes = 1.756 ± 0.41 (p < 0.0001), I-second 
expiratory rate = - 0.01493 ± 0.0056 (p = 0.008), triglyceride level 
(mg'dl- 1, natural logarithm transformation) = 0.4884 ± 0.169 (p = 
0.004), nonuse of internal mammary (thoracic) artery as a conduit 
(0 = no, I = yes) = 1.234 ± 0.29 (p < 0.0001). 
3. MuItivariable risk factor equation for death after the coronary 
bypass operation (UAB, 1986-1988 (6). For the single hazard phase 
(2-year followup), shaping parameter estimates and incremental risk 
factors, their coefficients, standard deviations and p values were: 
1 = 0.002167, 'Y = L a = 3.048, 1/ = L intercept = -10.24, age 
(years) = 0.06234 ± 0.0088 (p < 0.0001), left main disease (0 = no, 
:::::50% stenosis = I) = 0.3374 ± 0.192 (p = 0.08). number of prior 
myocardial infarcts = 0.3127 ± 0.118 (p = 0.008), myocardial 
infarction within 30 days of operation (0 = no, I = yes) = 0.4017 ± 
0.194 (p = 0.04), CASS left \'entricular wall motion score (score 
minus 5) = 0.04746 ± 0.020 (p = 0.02), hemodynamic instability 
without shock (0 = no, I = yes) = 1.359 ± 0.28 (0 < 0.000l), 
cardiogenic shock (0 = no, I = yes) = 1.919 ± 0.30 (p < 0.0001), 
nonuse of internal mammary (thoracic) artery as a conduit = 0.5498 
± 0.163 (p = 0.0007). 
4. MuItivariable risk factor equation for return of angina after the 
coronary bypass operation (KUL). For the three hazard phases, 
shaping parameters and incremental risk factors, their coefficients, 
standard deviations, and p values were: Early: [) = 0, p = 3.405, v = 
I, m = 0, intercept = -3.471, age (years) = -0.03833 ± 0.0114 
(p = 0.0008), severity of angina (0 = none, I = mild stable angina, 
2 = moderate or severe stable angina, 3 = severe nonexertional 
angina. 4 = unstable angina) = 0.2986 ± 0.096 (p = 0.002), 
peripherall'ascular disease (0 = no, I = yes) = 1.074 ± 0.22 (p < 
0.0001), mean quality of distal coronary vessels (0 = normal, 1 = 
diffuse but non stenosing disease, 2 = diffuse stenosing disease, 3 = 
diffuse stenotic disease requiring endarterectomy) = 0.3912 ± 0.143 
(p = 0.006), nonuse of internal mammary (thoracic) artery as a 
conduit to the left anterior coronary artery (0 = no, 1 = yes) = 
0.6233 ± 0.25 (p = 0.01), incomplete revascularization (0 = no, 1 = 
:::::70% stenosis remaining unbypassed) = 0.6849 ± 0.23 (p = 0.003), 
surgeon B (0 = no, 1 = yes) = 1.096 ± 0.25 (p < 0.0001). Constant: 
intercept = -7.780, gender (0 = male, I = female) = 0.7591 ± 0.117 
(p < 0.0001), absence of left main disease (:::::50% stenosis = 0, 
<50% stenosis = 1) = 0.5562 ± 0.182 (p = 0.002), left ventricular 
end-diastolic pressure (mm Hg) = 0.01618 ± 0.0075 (p = 0.03), 
severity of angina = 0.1219 ± 0.046 (p = 0.008), duration of anginal 
symptoms (months) = 0.004174 ± 0.00102 (p < 0.0001), mean 
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quality of distal coronary vessels = 0.2475 ± 0.074 (p = 0.0008). 
small coronary arteries (ratio of number of I mm or smaller distal 
coronary anastomoses to number of distal anastomoses) = 0.9316 ± 
0.23 (p < 0.0001). ascending aortic disease (0 = no. I = yes) = 
0.5289 ± 0.26 (p = 0.04), systemic hypertension (0 = no. I = systolic 
pressure 2: 160 mm Hg or diastolic pressure 2: 100 mm Hg) = 0.3586 
± 0.101 (p = 0.0004). Late: T = I. 'Y = L a = L 1] = 3.335. intercept 
= -21.74, duration of angina symptoms = 0.006292 ± 0.0021 (p = 
0.002), triglyceride level (mg'dl- ' , logarithmic transformation) = 
0.6123 ± 0.193 (p = 0.002), sequential grafting (the ratio of number 
of distal anastomoses to number of conduits + 0.5, natural logarithm 
transformation) = 1.409 ± 0.36 (p < O.OOO\). 
5. Incremental risk factor equation for acute myocardial infarc-
tion after the coronary bypass operation (KUL). For the two hazard 
phases, shaping parameter estimates and incremental risk factors, 
their coefficients, standard deviations and p values were: Early: 0 = 
0, p = 38.80, v = 2.685, m = 0, intercept = -2.152, unstable angina 
(0 = no, I = yes) = 0.6085 ± 0.26 (p = 0.02), number of conduits 
used = -0.4578 ± 0.143 (p = 0.001), incomplete revasculariz.ation 
(0 = no, I = 2:70% stenosis remaining unbypassed) = 0.6243 ± 0.26 
(p = 0.02), surgeon C (0 = no, I = yes) = -0.5678 ± 0.28 (p = 0.04). 
Late: T = I, 'Y = La = L 1] = 2.697, intercept = -47.16, age (years, 
natural logarithmic transformation) = 6.161 ± 2.9 (p = 0.03), age 
(lOO/years transformation) = 3.263 ± 1.30 (p = 0.01), unstable 
angina (0 = no, I = yes) = 0.4048 ± 0.176 (p = 0.02), diahetes (0 = 
no, I = glucose intolerance, 2 = oral hypoglycemic-treated, 3 = 
insulin-treated) = 0.3624 ± 0.108 (p = 0.0008), family history (it' 
coronary artery disease (0 = no, I = yes) = 0.3276 ± 0.146 (p = 
0.02), high density lipoprotein level (mg'dl- ' ) = -0.02057 ± 0.0097 
(p = 0.03), triglyceride level (mg·dl- ' , logarithmic transformation) = 
0.3456 ± 0.149 (p = 0.02), nonuse of internal mammarv (thoracic) 
artery as the conduit to the left anterior descending coronary artery 
= 0.4388 ± 0.174 (p = 0.01). 
6. Multivariable risk factor equation for sudden death after the 
coronary bypass operation (KUL). For the two hazard phases, 
shaping parameters, incremental risk factors and their coefficients, 
standard deviations and p values were: Constant: intercept = 
-9.188, absence of leli main disease (2:50% stenosis = 0, <50S( 
stenosis = I) = 1.590 ± 0.77 (p = 0.04), three vessel disease (0 = no, 
I = 2:70% stenosis of three vessels) = 1.240 ± 0.50 (p = O.O\), 
ejection fraction = -5.436 ± 1.00 (p < 0.0001), chronic stahle 
angina (0 = yes, I = no) = 1.084 ± 0.33 (p = 0.001), duration of 
anginal symptoms (months) = 0.006418 ± 0.0024 (p = 0.007). 
peripheral vascular disease (0 = no, I = yes) = 0.9315 ± 0.32 (p = 
0.004), ascending aortic disease (0 = none, I = calcified, 2 = thin 
and fragile, 3 = caseous malformation) = 0.4845 ± 0.20 (p = 0.(2). 
incomplete revascularization (0 = no, I = 2:70% stenosis remaining 
unbypassed) = 0.8215 ± OJO (p = 0.0(6). Late: T = I. y = I. a = I. 
1] = 3.724, intercept = -22.11 (no risk factors). 
7. Multivariable risk factor equation for cardiac death (Duke) 
after the coronary bypass operation. These equations are available 
(135). 
8. Multivariable risk factor equation for death after initial medical 
treatment for stable angina (VA). For the three hazard phases, 
shaping parameters and incremental risk factors, their coefficients, 
standard deviations, and p values were: Early: 0 = 0, p = 2.406, I' = 
-0.2495, m = 0, intercept = -10.51, left main disease, if no left 
ventricular impairment «50% stenosis = 0, 2:50% stenosis = I) = 
1.937 ± 1.06 (p = 0.07), leli main disease, if the left ventricle is 
impaired «50% stenosis = 0, 2:50% stenosis = I) = 3.358 ± 0.99 
(p = 0.0007), New York Heart Association functional class (\ to IV, 
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equivalent to Canadian angina class) = 2.060 ± 0.78 (p = 0.008). 
Constant: intercept = -5.463, left main disease «50% stenosis = 0; 
2:50% stenosis = I) = 1.141 ± 0.40 (p = 0.004), number of diseased 
vessels if the left ventricle is impaired (I to 3,2:50% stenosis, natural 
exponential transformation) = 0.05605 ± 0.017 (p = 0.0007), number 
of prerandomization myocardial infarcts = 0.3475 ± 0.139 (p = 
O.O\), severe anginal symptoms (VA angina score <12 = 0, score 
2:12 = I) = 0.4808 ± OJI (p = 0.1), ratio of weight to height 
(kg'cm- ' , inverse transformation) = -0.8038 ± 0.50 (p = 0.09), 
history of hypertension (0 = no, I = yes) = 1.135 ± 0.32 (p = 
0.0004). Late: T = L 'Y = I, a = 1,1] = 2.186, intercept = -9.081, 
ratio of weight to height (kg'cm- ' ) = -7.762 ± 3.4 (p = 0.02). 
9. Multivariable risk factor equation for acute myocardial infarc-
tion (fatal and nonfatal) after initial medical treatment for stable 
angina (VA). For the single hazard phase, incremental risk factors, 
their coefficients, standard deviations, and p values were: Early: 0 = 
0, p = 107.7, v = L m = L intercept = -1.470, left main disease 
«50% stenosis = 0, 2:50% stenosis = I) = 0.9894 ± 0.45 (p = 0.03), 
number of diseased vessels (I to 3,2:50% stenosis) = 0.2937 ± 0.144 
(p = 0.04), number of previous acute myocardial infarctions = 
0.2874 ± 0.110 (p = 0.009), history of hypertension (0 = no, I = yes) 
= 0.6793 ± 0.193 (p = 0.0004). 
10. Multivariable risk factor equation for a subsequent coronary 
bypass operation after initial medical treatment for stable angina 
(VA). Data from Blackstone EH, Kirklin JW, Peduzzi P, Takaro T, 
Hultgren HN. Outcome after randomization to initial medical treat-
ment in the V A randomized trial of chronic stable angina (unpub-
lished study, 1990). For the single hazard phase, incremental risk 
factors, their coefficients, standard deviations and p values were: 
Constant: intercept = -7.233, leli main disease «50% stenosis = 0, 
2:50% stenosis = I) = 1.325 ± 0.33 (p < 0.0001), two or three vessel 
disease «50% stenosis = 0, 2:50% stenosis = I) = 0.5161 ± 0.26 
(p = 0.04). no impairment of left ventricular contractility (0 = 
impairment, I = no impairment) = 0.3830 ± 0.166 (p = 0.02), VA 
angina score (I to 18) = 0.1109 ± 0.035 (p = 0.002), duration of 
pretreatment anginal symptoms (months) = 0.002941 ± 0.00148 
(p = 0.05). 
11. Multivariable risk factor equation for death, acute myocardial 
infarction and a subsequent coronary artery bypass operation after 
initial medical treatment for unstable angina (V A). (Data from 
Blackstone EH. Kirklin JW, Scott SM, Luchi RJ, Deupree RH. 
Outcome after randomization to initial medical treatment in the V A 
randomized trial of unstable angina (unpublished study, 1990). 
These equations are available on computer software. 
12. Multivariable risk factor equation for death after coronary 
angioplasty (VAB) (73). For the two hazard phases, shaping param-
eters and incremental risk factors, their coefficients, standard devi-
ations and p values were: Early: 0 = 0, p = 0.002288, lJ = I, m = 0, 
intercept = -5.958, number of previous myocardial infarctions = 
1.500 ± 0.64 (p = 0.02), cardiogenic shock (0 = no, I = yes) = 2.780 
± 1.16(p = 0.02). Constant: intercept = -7.645, number of diseased 
l'essels 0-3, 2:70% stenosis) = 1.039 ± 0.26 (p < 0.0001), cardio-
genic shock = 4.412 ± 0.59 (p < 0.0001), ethnicity (0 = white, I = 
black) = 1.380 ± 0.43 (p = 0.001), diabetes (0 = no, I = yes) = 1.234 
± 0.39 (p = 0.0(2). 
13. Multivariable risk factor equation for angina after coronary 
angioplasty (UAB) (73). For the single hazard phases, shaping 
parameters and incremental risk factors, their coefficients, standard 
deviations and p values were: T = 0.008162, 'Y = I, a = 2.521, 1] = 
I, intercept = -4.197, number of diseased vessels (I to 3, 2:50% 
stenosis) = 0.4092 ± 0.136 (p = 0.003), important hyperlipidemia 
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(0 = no important hyperlipidemia, 1 = important hyperlipidemia 
before angioplasty) = 0.9332 ± 0.43 (p = 0.03). 
14. MuItivariable risk factor equation for acute myocardial in-
farction (excluding infarctions in immediate proximity to the angio-
plasty site and considering only preangioplasty variables) after coro-
nary angioplasty (VAB) (73). For the two hazard phases, shaping 
parameters and incremental risk factors, their coefficients, standard 
deviations, and p values were: Early: 8 = 0, p = 1.399, v = -0.2293, 
m = 0, intercept = -4.761 (no risk factors). Constant: intercept = 
-8.790, number of previous myocardial infarcts = 1.654 ± 0.58 (p = 
0.004), acute myocardial infarction between 24 hand 2 weeks before 
angioplasty (0 = no, 1 = yes) = 1.498 ± 0.87 (p = 0.09). 
15. Multivariable risk factor equation for repeat angioplasty after 
coronary angioplasty (VAB) (73). For the two hazard phases, shaping 
parameters and incremental risk factors, their coefficients, standard 
deviations and p values were: Early: T = I, 'Y = 1, a = I, 1/ = 0.2711, 
intercept = -5.069, incomplete revascularization (no vessel disease 
;:::50% stenosis = 0, remaining postangioplasty vessel disease ;:::50% 
stenosis = I) = 2.061 ± 1.03 (p = 0.05), angioplaster (0 = no, 1 = 
yes) = 1.125 ± 0.45 (p = 0.01). Later (peaking): 8 = 0, p = 2.616, 
v = 0.2480, m = 0, intercept = -2.532, number of diseased vessels 
(I to 3, ;:::50% stenosis, natural exponential transformation) = 0.1229 
± 0.036 (p = 0.0006), no previous myocardial infarcts (0 = previous 
infarcts, 1 = no infarcts) = 1.812 ± 0.71 (p = 0.01), number of 
lesions dilated = -1.650 ± 0.84 (p = 0.05). 
16. Multivariable risk factor equation for the coronary bypass 
operation (preangioplasty variables only) after angioplasty (VAB) 
(73). For the two hazard phases, shaping parameters and incremen-
tal risk factors, their coefficients, standard deviations and p values 
were: Early: 8 = 0, p = 0.003292, v = -0.08466, m = 4.206, 
intercept = -8.193, ratio of weight to height (kg·cm- I ) = 10.92 ± 
6.0 (p = 0.07). Late: T = 1, 'Y = I, a = I, 1/ = 0.5006, intercept = 
-12.45, ratio of weight to height = 12.66 ± 3.3 (p = 0.0002), number 
of diseased vessels (1 to 3, ;:::70% stenosis, natural exponential 
transformation) = 0.1323 ± 0.041 (p = 0.001), proximal left anterior 
descending coronary artery disease (0 = <50% stenosis, 1 = ;:::50% 
stenosis) = 1.213 ± 0.39 (p = 0.002), proximal right coronary artery 
disease (0 = <70% stenosis, 1 = ;:::70% stenosis) = 0.9517 ± 0.45 
(p = 0.03), ejection fraction = 2.799 ± 1.50 (p = 0.06), hemody-
namic instability (0 = no, 1 = yes) = 1.339 ± 0.47 (p = 0.004). 
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